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in the regulation of cellular excitability and axonal conduction. Previous studies have shown that peripheral
sensory neurons express Kv7.2, Kv7.3, and Kv7.5 subunits, and that suppression of Kv7 activity with
pharmacological blockers can lead to increased nociception. However, the specific localization and the
functional role of each Kv7 subunits within the peripheral sensory system have not been fully elucidated. In
this thesis, I first investigate the expression pattern of Kv7.5 with immunohistochemical techniques, which
allow me to show that Kv7.5 is localized in the axons of the Remak bundles (unmyelinated axons and their
associated Schwann cells), including their cutaneous branches, and is not detected at nodes of Ranvier. In
addition, I demonstrate that small diameter neurons in the dorsal root ganglia (DRG), which are the origin of
these unmyelinated afferents, express relatively more Kv7.5 than do large DRG neurons. Thus, Kv7.5 may be
the relevant Kv7 channel expressed by C-fibers. Next I examined Kv7.2 with the generation of conditional
Kcnq2-null mice that lacked Kv7.2 expression in all peripheral sensory neurons. I show that Kcnq2-null mice
have a complete loss of Kv7.2 expression in the peripheral sensory neurons, but retain normal Kv7.3 nodal
expression and other molecular components of the node, paranode, and juxtaparanode. Furthermore, the
Kcnq2-null mice exhibit normal motor performance, but have increased thermal hyperalgesia and mechanical
allodynia. Finally, by utilizing whole cell patch recording technique, I demonstrate that Kcnq2-null DRG
neurons have increased excitability and reduced spike-frequency adaptation. Taken together, the results that I
have generated in this thesis suggest that in the peripheral sensory system, Kv7.5 provides the primary M-
current in unmyelinated axons, while Kv7.2 regulates the excitability of myelinated axon.
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ABSTRACT 
 
THE ROLE OF KV7 IN PERIPHERAL NEURONS 
Chih Houng King 
Supervisor: Steven S. Scherer 
 
The Kv7 (KCNQ) channel is a family of voltage-gated potassium channels that is 
considered to be important in the regulation of cellular excitability and axonal 
conduction. Previous studies have shown that peripheral sensory neurons express Kv7.2, 
Kv7.3, and Kv7.5 subunits, and that suppression of Kv7 activity with pharmacological 
blockers can lead to increased nociception. However, the specific localization and the 
functional role of each Kv7 subunits within the peripheral sensory system have not been 
fully elucidated. In this thesis, I first investigate the expression pattern of Kv7.5 with 
immunohistochemical techniques, which allow me to show that Kv7.5 is localized in the 
axons of the Remak bundles (unmyelinated axons and their associated Schwann cells), 
including their cutaneous branches, and is not detected at nodes of Ranvier. In addition, I 
demonstrate that small diameter neurons in the dorsal root ganglia (DRG), which are the 
origin of these unmyelinated afferents, express relatively more Kv7.5 than do large DRG 
neurons. Thus, Kv7.5 may be the relevant Kv7 channel expressed by C-fibers. Next I 
examined Kv7.2 with the generation of conditional Kcnq2-null mice that lacked Kv7.2 
expression in all peripheral sensory neurons. I show that Kcnq2-null mice have a 
complete loss of Kv7.2 expression in the peripheral sensory neurons, but retain normal 
Kv7.3 nodal expression and other molecular components of the node, paranode, and 
 vii 
juxtaparanode. Furthermore, the Kcnq2-null mice exhibit normal motor performance, but 
have increased thermal hyperalgesia and mechanical allodynia. Finally, by utilizing 
whole cell patch recording technique, I demonstrate that Kcnq2-null DRG neurons have 
increased excitability and reduced spike-frequency adaptation. Taken together, the results 
that I have generated in this thesis suggest that in the peripheral sensory system, Kv7.5 
provides the primary M-current in unmyelinated axons, while Kv7.2 regulates the 
excitability of myelinated axon. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
Peripheral myelinated and unmyelinated axons 
The axons in the peripheral nervous system (PNS) can be divided into two broad classes - 
the myelinated and the unmyelinated axons. The myelinated axons are organized into 
several domains - the node of Ranvier, the paranode, the juxtaparanode, and the 
internode, and this organization is critical to the propagation of action potential by the 
mechanism of saltatory conduction (Poliak and Peles, 2003, Salzer et al., 2008). Schwann 
cells, which unlike oligodendrocytes in the central nervous system (CNS) can only 
myelinate one internode of a single axon, form myelin sheath by enwrapping their 
membrane several times around the axon (Poliak and Peles, 2003); the multi-lamellar 
structure of the myelin sheath serves to both increase membrane resistance as well as 
limit the generation of action potentials to the nodes, thus dramatically increasing the 
conduction velocity of myelinated axons. Of course, the most important domain of the 
myelinated axon is the node, where there is a very high concentration of voltage-gated 
sodium channels (Poliak and Peles, 2003, Salzer et al., 2008), and is also where the 
voltage-gated Kv7 potassium channels are expressed (Devaux et al., 2004); the co-
localization of Kv7 channels with the voltage-gated sodium channels (Nav) at nodes (and 
axonal initial segments) allows Kv7 channels to contribute to the regulation axonal 
excitability, as I will discuss below. Notably, the co-localization of both Nav and the 
Kv7.2 and Kv7.3 channels owes to a consensus ankyrin-G binding domain at their C-
termini (Pan et al., 2006), which is absent in all other Kv7 subunits. Finally, the nodes of 
peripheral axon are normally ~1 µm long and are contacted by Schwann cell microvilli, 
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which closely appose the nodal axolemma (Salzer et al., 2008); in chapter 3 of this thesis 
I will compare the ultrastructure of Kcnq2-null myelinated axons against wild-type 
myelinated axons. 
 Unlike the CNS, which contains relatively few unmyelinated axons, the PNS 
contains many unmyelinated axons (Griffin and Thompson, 2008). The unmyelinated 
fibers, referred to as Remak fibers (because they were first characterized by Robert 
Remak 170 years ago; (Remak, 1838)), include the C-fibers, the postganglionic 
sympathetic fibers, and some of the preganglionic sympathetic and parasympathetic 
fibers (Griffin and Thompson, 2008). Unmyelinated axons lack the distinct domains of 
myelinated axons, and Nav and Kv7 channels are expressed along the entire length of the 
membrane (Giuliodori and DiCarlo, 2004); the lack of saltatory conduction, along with 
decrease membrane resistance, result in the substantially slower conduction velocity of 
the Remak fibers. For example, C-fibers, have a conduction velocity of < 1 m/s, versus 5-
30 m/s for the thinly-myelinated A-delta fibers (Fields, 1987).  Lastly, unlike myelinating 
Schwann cells, Remak Schwann cells often ensheath more than one axon (Griffin and 
Thompson, 2008). 
 
Kv7 channels and M-current 
The Kv7 (KCNQ) family of potassium channels is made up of five members: Kv7.1 to 
Kv7.5, and mutation of KCNQ genes contribute to a number of inherited neuropathies. 
Kv7.1 is the only Kv7 subunit known to be expressed in the heart, and dominant mutation 
of Kv7.1 can lead to long-QT syndrome, a potentially fatal form of cardiac arrhythmia 
(Wang et al., 1996). Kv7.2 and Kv7.3 is found in a wide variety of nervous tissues within 
 3 
the CNS and PNS (Jentsch, 2000, Robbins, 2001), and dominant mutation of KCNQ2 or 
KCNQ3 cause benign familial neonatal convulsions, a form of generalized epilepsy 
during the neonatal period (Singh et al., 1998). The expression of Kv7.4 is primarily 
restricted to the auditory and vestibular system, and dominant mutant of KCNQ4 can lead 
to progressive hearing loss caused by degeneration (Van Camp et al., 2002). Lastly, 
Kv7.5 has been found to be expressed in the brain (Schroeder et al., 2000), peripheral 
sensory neurons (Passmore et al., 2003), as well as muscles; unlike the other Kv7 
subunits, no human disease has yet been linked to mutation of KCNQ5 (Jentsch, 2000). 
These Kv7-mediated channelopathies illustrate the important functional role that Kv7 
channels play in the regulation of cellular excitability, by generating a type of potassium 
current known as the M-current (IM) (Wang et al., 1998). The M-current (so-called 
because it can be modulated by muscarinic agonists (Brown and Adams, 1980), is a type 
of slowly activating current that does not become inactivated. Because of its low 
activation threshold (at around -60 mV) (Lamas et al., 2002, Brown and Passmore, 2009), 
it helps to maintain the resting membrane potential. In addition, because M-current does 
not become inactivated after depolarization, it plays an important role in the regulation of 
neuronal excitability by reducing firing frequency during prolonged stimulation (Rivera-
Arconada et al., 2009), thus mediating spike-frequency adaptation (Gu et al., 2005, Peters 
et al., 2005). Indeed, numerous studies have demonstrated that the administration of M-
blockers decrease spike-frequency adaptation and increase firing rates of both central 
(Aiken et al., 1995, Yue and Yaari, 2004, Gu et al., 2005, Shah et al., 2008) and 
peripheral (Passmore et al., 2003, Wladyka and Kunze, 2006, Wladyka et al., 2008) 
neurons. 
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 Beside the aforementioned ankyrin-G binding motif, the C-termini of Kv7 
subunits also contains a putative assembly domain that is thought to be involved in 
subunit assembly, at least in Kv7.1 (Jentsch, 2000, Schmitt et al., 2000). All Kv7 
channels can form homomeric channels (i.e. with themselves) in vitro (Jentsch, 2000), 
while a subset of the Kv7 subunits can form heteromeric channels. For example, while 
Kv7.1 can only form homomeric channels, Kv7.2, Kv7.4, and Kv7.5 can form 
heteromeric channels with Kv7.3 (Kubisch et al., 1999, Schroeder et al., 2000, Cooper, 
2011), and Kv7.4 and Kv7.5 can also form heteromeric channels (Bal et al., 2008). In the 
myelinated axon, Kv7.2 and Kv7.3 had been shown to co-localize at nodes (Pan et al., 
2006), and a recent study suggest that proper localization of Kv7.3 at nodes and axon 
initial segment depends on Kv7.2 (Gomez-Posada et al., 2010). I will address these points 
in chapter 3 of this thesis by examining the expression pattern of both Kv7.2 and Kv7.3 
in the myelinated axons of my Kcnq2-null mice.  
 
Kv7 blockers and enhancers 
 As mentioned earlier, in studies of the Kv7 channels, one of the most common 
tools that the researchers utilized is M-channel blockers, and the two most commonly 
used compounds are linopirdine and its successor XE991; linopirdine was the first 
selective Kv7 blocker developed, originally designed as a cognitive enhancer for the 
treatment of neurodegenerative diseases such as Alzheimer's disease (Tam and Zaczek, 
1995); however, due to the relatively high dose required to inhibit M-current, linopirdine 
was found to cause tremors through cholinergic hyperstimulation (Miceli et al., 2008, 
Brown and Passmore, 2009), and other compounds, such as XE991, were later designed 
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to try to overcome this shortcoming. However, with the exception of Kv7.5 (Schroeder et 
al., 2000), both linopirdine and XE991 are relatively non-selective again other Kv7 
channels (Wang et al., 1998), so utilizing these compounds for both experimental and 
treatment purposes carry the risk of inhibiting cardiac Kv7.1 channels and causing fatal 
arrhythmia (Wang et al., 2000). However, one compound that does not share this 
disadvantage is tetraethylammonium (TEA), which is much more sensitive against the 
Kv7.2 subunit (Hadley et al., 2000). Specifically, the TEA's IC50 value for Kv7.2 (0.3 
mM) is at least 10 times less than for the other Kv7 subunits (the IC50 values for Kv7.1, 
Kv7.3, Kv7.4, and Kv7.5 are: 5.0mM, >30 mM, 3.0 mM, and 70 mM, respectively; 
(Hadley et al., 2000, Schroeder et al., 2000)), and this sensitivity is likely due to the 
presence of a tyrosine residue in the pore loop of the channel (Kavanaugh et al., 1991). 
Indeed, I used TEA at a Kv7.2-specific concentration (at 3mM) in chapter three of my 
thesis to investigate if the decreased spike-frequency adaptation exhibited by my Kcnq2-
null neurons could be attributed to the lack of Kv7.2 expression.  
 In several of the aforementioned studies on neuronal excitability, the authors had 
also used Kv7 enhancers such as retigabine in order to increase Kv7 channel activity. 
Interestingly, the Kv7.1 subunit is completely insensitive to retigabine, and this 
selectivity was used to determine that retigabine binding requires the presence of a 
tryptophan in the S5 domain of Kv7 channels (Schenzer et al., 2005) and also that 
retigabine enhances Kv7 activity by stabilizing the open state and increasing the opening 
time of the channel (Tatulian and Brown, 2003). In addition, retigabine's selectivity for 
Kv7.2-7.5 over the cardiac Kv7.1 subunit also provides a practical safety advantage when 
used in animals. Finally, when administered to both central and peripheral neurons, 
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retigabine produces the opposite effect of linopirdine or XE991, and results in 
hyperpolarization and decreased firing rates (Passmore et al., 2003, Yue and Yaari, 2004, 
Gu et al., 2005, Lang et al., 2008). 
 
Kv7 and nociception 
In general, there are three major classes of nociceptors - thermal, mechanical, and 
polymodal, whose cell bodies are all located in the dorsal root ganglia (DRG) and the 
trigeminal ganglia. Both thermal (> 45oC or < 5oC) and mechanical nociceptors have 
thinly myelinated A-delta fibers, and polymodal nociceptors have unmyelinated C-fibers 
(Fields, 1987). As was mentioned earlier, A-delta fibers have a much higher conduction 
velocity compared to C-fibers, therefore when noxious stimuli are sensed, the sharp "first 
pain" is carried by the A-delta fibers, while the dull "second pain" is carried by the C-
fibers; these signals are then passed onto projection neurons in the dorsal horn of the 
spinal cord (Fields, 1987). It should be noted that pain can be divided into two general 
classes - acute pain and persistent pain, and the latter class can further be subdivided into 
nociceptive and neuropathic pain. While both acute and nociceptive pain usually can be 
controlled with traditional analgesics, neuropathic pain, which is pain caused by a 
primary dysfunction of the nervous system, is much more refractory to treatments 
(Suzuki and Dickenson, 2000, Suzuki et al., 2002). Because DRG neurons express Kv7.2, 
Kv7.3, and Kv7.5 (Passmore et al., 2003), Kv7 channels are thought to play an important 
role in the regulation of nociception, and Kv7 enhancers represent a promising method 
for the treatment of pain, especially for neuropathic pain. Both chapter 2 and chapter 3 of 
this thesis are devoted to investigating the expression of Kv7.2, Kv7.3, and Kv7.5 in 
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peripheral sensory neurons. First, I used immunohistochemical techniques to determine 
which Kv7 subunit is expressed by the unmyelinated C-fibers and their cell bodies in the 
dorsal root ganglia. Next, I use the Cre-Lox system (Sauer and Henderson, 1988) to 
selectively knockout Kv7.2 expression in all peripheral sensory neurons. I then assess the 
nociceptive behaviors of the Kcnq2-null mice to noxious thermal and mechanical stimuli 
with the Hargreaves' test and the von Frey hair filament test, respectively. Finally, 
because previous studies have shown that the application of Kv7-blockers in peripheral 
sensory neurons decrease spike frequency adaptation and increase firing rate (Passmore 
et al., 2003, Wladyka and Kunze, 2006), I use whole cell patch-recording technique to 
see if Kcnq2-null DRG neurons have decreased spike frequency adaptation.
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CHAPTER 2: KV7.5 IS THE PRIMARY KV7 SUBUNIT EXPRESSED IN C-
FIBERS 
 
INTRODUCTION 
The Kv7 (KCNQ) family of K+ channels was originally characterized by their 
modulation by muscarinic agonists, giving rise to the name M-currents (Brown and 
Adams, 1980, Wang et al., 1998). In mammals, there are five Kv7 channels, Kv7.1-7.5; 
all can form homomeric channels, and Kv7.3 can form heteromeric channels with either 
Kv7.2 or Kv7.5 (Jentsch, 2000, Schroeder et al., 2000). All Kv7 channels are slowly 
activated by depolarization and play an important role in maintaining normal resting 
membrane potential. Dominant mutations of KCNQ2 or KCNQ3 cause benign familial 
neonatal convulsions, a form of generalized epilepsy confined to the neonatal period 
(Singh et al., 1998). In addition, at least one KCNQ2 mutation also causes neuromyotonia 
(Dedek et al., 2001), which is characterized by excessive excitability of distal motor 
axons.  
We have previously shown that Kv7.2 and Kv7.3 channels are highly enriched in 
axon initial segments (AISs) and nodes of Ranvier (Devaux et al., 2004). Their 
localization owes to a consensus ankyrinG-binding motif in the intracellular carboxy-
terminus (Pan et al., 2006). This motif is present in all vertebrate voltage-gated Na+ 
channels (Nav1.1-1.9), Kv7.2, and Kv7.3, but not in Kv7.1, Kv7.4, or Kv7.5 - a unique 
example of convergent evolution at the molecular level (Hill et al., 2008). 
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Kv7.5 mRNA has been detected in the small neurons of the dorsal root ganglia 
(DRG) (Passmore et al., 2003), but the localizations of the Kv7.5 protein in peripheral 
nerves and DRG are unknown. We show here that Kv7.5 is localized in the axons of the 
Remak bundles (unmyelinated axons and their associated Schwann cells), including their 
cutaneous branches, and is not detected at nodes of Ranvier. Furthermore, small diameter 
DRG neurons, the origin of these unmyelinated afferents, express relatively more Kv7.5 
than do large DRG neurons. Thus, Kv7.5 may be the relevant Kv7 channel expressed by 
C-fibers. 
 
MATERIALS AND METHODS 
Animal and tissue sections 
All procedures involving rodents were approved by the Institutional Animal Care 
and Use Committee of the University of Pennsylvania. 8-10 weeks old adult Sprague 
Dawley rats (n=3) or C57BL/6 mice (n=3) were anesthetized with ketamine/xylazine mix 
and killed by decapitation. Sciatic nerves, dorsal root ganglia (from L4-L6 spinal levels), 
and skin (both hairy and glabrous) were dissected, and quickly embedded in OCT cooled 
in an acetone/dry ice slurry. The sciatic nerve fibers were teased apart with fine needles, 
mounted on SuperFrost Plus glass slides (Fisher Scientific, Pittsburgh, PA), dried 
overnight, and stored at -20oC. Ten µm thick cryostat sections were thaw-mounted onto 
Superfrost slides, and stored at -20oC.  
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Immunohistochemistry 
Teased fibers and OCT sections were immersed in -20oC acetone for 10 minutes, 
rinsed in PBS, blocked at room temperature for one hour in PBS containing 5% fish skin 
gelatin and 0.5% Triton X-100, and incubated overnight at 4oC with various combination 
of primary antibodies diluted in blocking solution. The slides were washed with PBS, 
incubated with the appropriate FITC-, TRITC-, and Cy5-conjugated donkey cross-
affinity-purified secondary antibodies (Jackson ImmunoResearch, 1:200) at room 
temperature for one hour, washed with PBS, counterstained with 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Invitrogen), mounted with Vectashield (Vector 
Laboratories), examined by epifluorescence on a Leica DMR light microscope with a 
cooled Hamamatsu camera under the control of Openlab software (Openlab, 
Improvision). When necessary, digital images were cropped and RGB histogram adjusted 
to fill entire tonal range using Photoshop (Adobe). 
 
Antibody Characterization 
Please see Table 2-1 for a summary of all primary antibodies used. The KCNQ2N 
antiserum (Cooper et al., 2001) stained nodes and AISs of teased nerve fibers in an 
identical pattern as previously shown (Devaux et al., 2004, Pan et al., 2006) In addition, 
using the Lipofectamine 2000 kit (Invitrogen) with method as previously described 
(Rasmussen et al., 2007), the KCNQ2N antiserum positively stained Hela cells that were 
transiently transfected with the cDNA encoding human Kv7.2 (kindly provided by Dr. 
Edward Cooper), but did not stain Hela cells transfected with human Kv7.5 cDNA 
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(kindly provided by Dr. Thomas Jentsch). Finally, the nodal staining by the KCNQ2N 
antiserum was abolished in tissues of a Kv7.2 conditionally-null mouse, but was 
preserved in tissues of a wild-type littermate. The KCNQ3C antiserum also stained nodes 
in an identical pattern as previously described (Pan et al., 2006). 
The sequences of immunogen targeted by the KCNQ5 antiserum (Chemicon 
AB5599) and the Kv7.5 antiserum (Chemicon AB9792) are shown in Figure 2-1. Both 
antisera were able to positively label Hela cells transfected by the Kv7.5 cDNA but did 
not label Hela cells transfected by the Kv7.2 cDNA. In addition, peptide-blocking was 
performed, whereby slides of rat sciatic nerves and DRG were stained according to the 
above protocol, except that the AB5599 and the AB9792 Kv7.5 antisera (along with the 
panNav antibody) were preincubated with the purified peptide for the AB9792 antiserum 
(10 μg peptide per 1 μg of antibody in 100μl for 12 hours at 37°C. The mixtures were 
then centrifuged for 15 minutes at 13,000 rpm, and the supernatant was used in the 
primary antibody step); the blocking experiment was repeated three times, and when 
images were taken with the microscope, identical exposure time was used for all blocking 
conditions. Pre-incubation with immunogen of AB9792 was able to diminish AB9792 
staining of all tissues, but did not change AB5599’s staining. 
The panNav monoclonal antibody targets multiple voltage-gated Na+ channels, 
and has previously been shown to specifically stain the AISs and nodes of a wide range 
of nervous tissues (Rasband et al., 2001, Devaux et al., 2004, Pan et al., 2006) in our 
stainings it recognized the nodes of both rat and mouse sciatic nerves, as expected. 
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The TrkA antiserum has been shown by the manufacturer to be able to detect rat 
TrkA in both direct ELISAs and Western blots, with less than 1% cross-reactivity with 
recombinant mouse TrkB and TrkC. It has been previously shown to label primarily 
small and medium sized rat DRG cells (Averill et al., 1995), and in our immunostaining 
of rat DRG sections the TrkA antiserum labeled primarily small and medium size 
neurons as well. 
IB4 lectin is derived from Bandeiraea simplicifolia and binds to cells surface 
glycoprotein of GDNF-sensitive small diameter DRG neurons (Kashiba et al., 2001). In 
our staining we used biotin-conjugated IB4 lectin, and we observed that it preferentially 
labeled small diameter DRG neurons, as had been shown previously (Ivanusic, 2009). 
The MAG antiserum recognizes the extracellular domain of rat myelin-associated 
glycoprotein, and was able to recognize rat MAG in direct ELISAs and Western blots 
according to the manufacturer’s datasheet. In our evaluation of immunohistochemical 
staining, it strongly labeled myelin shealth, as expected. 
The NFH monoclonal antibody, recognized neurofilament heavy subunits as was 
previously shown both by ELISA, and also by the peroxidase-antiperoxidase method to 
specifically stained axons and neurons in human cerebellum sections (Lee et al., 1982). In 
our immunostaining of rat sciatic nerve it labeled axons, but not myelin sheath. 
The glial fibrillary acidic protein (GFAP) antiserum recognizes a single band of 
51 kDa band on immunoblot of cytoskeleton-enriched rat spinal cord lysate, and has been 
shown to stain glial elements and astrocytes (Lee et al., 1984). When we stained rat 
sciatic nerve, the antibody labeled non-myelinated Schwann cells, consistent with other 
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studies using anti-GFAP antisera (Jessen et al., 1985, Jessen et al., 1990, Cheng and 
Zochodne, 2002).  
  
Kv7.5 Quantification 
DRG sections from three rats were triple-stained with Kv7.5 AB5599 antiserum, 
IB4 lectin, and TrkA antiserum, and imaged with a Leica Sp2 confocal microscope 
system. The embedding, sectioning, staining, and imaging were done in parallel. 
Intensities of the three secondary antibodies specific to each of the primary antisera were 
measured by using NIH ImageJ, and cytoplasmic intensity were calculated by subtracting 
the nucleus intensity from the whole cell intensity. Data collected in Microsoft Excel, and 
the Student’s t-tests were performed using SAS 9.2 (SAS). For the comparison between 
IB4 and TrkA staining, a threshold of 20 was selected as the cutoff for clear positive 
staining. 
 To quantify mRNA level of Kv7.5, 3 samples of total RNA isolated from young 
adult rat sciatic nerve and DRG by CsCl2 gradient centrifugation (Chirgwin et al., 1979) 
was amplified and analyzed with the SuperScript One-Step RT-PCR with Platinum Taq 
system (Invitrogen 10928-042) according to manufacturer protocol. NCBI Primer-
BLAST using known Rattus norvegicus mRNA sequence was used to design primer sets 
complementary to rat KV7.5 (forward, ACGTCACCACCTGCCTTGTTG; reverse, 
TGTAAGTTCAGTTCCTCTGTCGATCT) and myelin-associated glycoprotein (MAG; 
forward, AGCCACCGCCTTCAACCTGT; reverse, TGGCAAAGGCGACCACAGCA). 
To rule out genomic DNA contamination, 2 units of Platinum Taq DNA polymerase 
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(Invitrogen 10966-034) were used instead of the RT/Platinum Taq Mix in the reaction.  
The RT-PCR of the sciatic nerve total RNA sample was repeated 3 times. 
 Axotomy was performed on anesthetized (60 mg/kg of ketamine, 7.5 mg/kg of 
xylazine) 30-day-old Sprague Dawley rats (n=3). The sciatic nerve was exposed at the 
sciatic notch and transected with iridectomy scissors, and the skin incision was closed 
with wound clips. Four days after the surgery the animals were euthanized, and the sciatic 
nerve segment distal to the transection site, as well as the corresponding contralateral 
sciatic nerve segment, were dissected and teased onto slides, and were immunostained 
with previously described antisera. For image recording, identical exposure times were 
used for both the transected and contralateral teased fibers. 
 
RESULTS 
Kv7.5 is localized to Remak bundles 
We immunostained unfixed teased fibers from rat sciatic nerves for Kv7.2 or 
Kv7.5, combined with a mouse monoclonal antibody against voltage-gated Na+ channels 
(panNav). As shown in Figure 2-2, nodes of Ranvier were strongly Kv7.2- and panNav-
positive, as we have previously shown (Devaux et al., 2004, Pan et al., 2006). Remak 
bundles were panNav-positive, but were not detectably labeled by the Kv7.2 antiserum. 
The Kv7.5 antiserum (Chemicon AB9792) produced the reciprocal result: nodes were not 
labeled, whereas Remak bundles were Kv7.5- (and panNav-) positive. Another Kv7.5 
antiserum produced the same staining pattern (Chemicon AB5599; data not shown).  
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Because Kv7.5 can form heteromeric channels with Kv7.3 in vitro (Schroeder et 
al., 2000), we investigated whether Kv7.3 is also present in Remak bundles.  The 
KCNQ3C antiserum we have used does not label rat tissues well (due to the possibility 
that targeted residues of KCNQ3C is not conserved in rat; see Pan et al. (2006)), so we 
immunostained unfixed mouse teased fibers with the Kv7.2, Kv7.3, or Kv7.5 (Chemicon 
AB5599) antisera, combined with the panNav mouse monoclonal antibody.  Similar to 
the above results, the Kv7.2 and Kv7.3 antisera labeled nodes but not the Remak bundles 
(Figure 2-3), while the Kv7.5 antiserum produced the opposite result, labeling the Remak 
bundles but not the nodes. Therefore, Kv7.5 likely forms homomeric channels, but not 
heteromeric channels with Kv7.3, in Remak bundles. In a separate experiment, the Kv7.2 
antiserum was used on a Kcnq2-null mouse, and the Kv7.2 staining of the nodes was 
abolished (with intact Kv7.3 nodal staining), thereby demonstrating the specificity of our 
Kv7.2 antiserum (Chapter 3). 
The Chemicon AB9792 and AB5599 Kv7.5 antisera also produced granular 
staining of myelinated fibers (Figure 1, chevrons). Specifically, much of the granular 
staining lies outside of the neurofilament-positive axons, but resides with the myelin 
sheaths (Figure 2-4). These two Kv7.5 antisera were raised against partially overlapping 
sequences of the intracellular N-terminus; this entire region shares little homology with 
Kv7.2. To ascertain their specificity, HeLa cells were transiently transfected to express 
either Kv7.2 or Kv7.5. Cells expressing Kv7.5, but not Kv7.2, were strongly labeled by 
both Kv7.5 antisera. Conversely, cells expressing Kv7.2, but not Kv7.5, were robustly 
labeled with the Kv7.2 antiserum but not by either Kv7.5 antisera (Figure 2-5). 
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To determine whether the Kv7.5 expression in the Remak bundles originates from 
axons or the surrounding Schwann cells, we immunostained teased fibers from the distal 
nerve stump of sciatic nerves 4 days post-transection. At this time, axons distal to the 
injury have degenerated, while their associated Schwann cells persist (Griffin and 
Thompson, 2008). Denervated Remak bundles were not panNav- or Kv7.5-positive, 
whereas Remak Schwann cells were GFAP-positive (Figure 2-6). These results support 
the idea that Remak axons and not Remak Schwann cells express Kv7.5. While there 
exist the possibility that the disappearance of Kv7.5 staining is due to a loss of its 
expression from the Schwann cells rather than from the axons after nerve injury, we feel 
that this is a less likely explanation given the concurrent loss of panNav staining with the 
retention of robust GFAP staining, suggesting the loss of axons and the continued 
presence of its associated Schwann cells. In addition, as we will show, expression of 
Kv7.5 by the small diameter DRG neurons also indicate that the loss of Kv7.5 staining is 
from the axons, since they originate from these DRG neurons. Finally, we performed a 
blocking experiment, utilizing the purified immunogen for the AB9792 antiserum. As 
shown in Figure 2-7, pre-incubation with the peptide eliminated the labeling of Remak 
bundles, and seemed to reduce granular staining of myelinated axons.  
We were suspicious that the granular staining of Kv7.5 represents background 
staining, as we are unaware of other antigens that are localized in this pattern. To 
investigate this, we performed RT-PCR on RNA samples prepared from rat sciatic nerve 
and DRG, with primer pairs for rat Kv7.5 and MAG (Figure 2-8). Both the MAG and the 
Kv7.5 primers amplified the correctly sized products in both the sciatic nerve and the 
DRG RNA samples. In order to rule out the possibility of genomic DNA contamination 
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in the RNA samples, we substituted DNA polymerase in place of the RT-PCR 
polymerase mix. In this case, the Kv7.5 primers did not amplify a product in either the 
sciatic nerve or the DRG sample, but it did amplify the expected size product from a 
DNA sample (result not shown). Thus, we cannot rule out the possibility that the granular 
staining of Kv7.5 of myelin sheaths is authentic. 
 
Small DRG neurons express Kv7.5 
The largest and smallest axons in peripheral nerves originate from the largest and 
smallest neurons in DRG, respectively (Perry et al., 1991, Lozeron et al., 2004). To 
determine which neurons expressed Kv7.2 and Kv7.5, we immuno-stained unfixed 
sections of rat dorsal root ganglia (Figure 2-9). The Kv7.2 antiserum predominantly 
labeled large diameter neurons (which were largely panNav-negative), including their 
stem processes, which have many of the molecular features of nodes (Figure 2-10). In 
contrast, the AB9792/Kv7.5 antiserum predominately labeled the smaller neurons, which 
were mostly panNav-positive. The other Kv7.5 antiserum (AB5599) gave similar results 
(data not shown). To quantify these results, we used NIH ImageJ to calculate the mean 
Kv7.5 (AB9792) immuno-fluorescence for individual DRG neurons imaged by confocal 
microscopy. As shown in Figure 2-11, for three different rats, there is a negative 
correlation between cell size and Kv7.5 labeling, with the majority of the highly labeled 
cells (fluorescence intensity >20) having small diameters. Similar to the sciatic nerve, 
pre-incubation with the cognate peptide greatly diminished the staining of neurons by 
AB9792 (Figure 2-12).  
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Small DRG neurons can be divided into either NGF sensitive neurons that express 
TrkA (Averill et al., 1995) and the GDNF sensitive neurons that express glycoprotein that 
can bind to IB4 (Kashiba et al., 2001), and because both of these neurons give off 
unmyelinated C fibers, both IB4 and TrkA serve as neurochemical markers of 
nociceptive neurons (Averill et al., 1995, Molliver et al., 1997, Kashiba et al., 2001, 
Priestley et al., 2002). To investigate this issue further, we triple-labeled sections of DRG 
from three individual rats for Kv7.5, IB4, and TrkA (Figure 2-13). As expected, almost 
all of the small DRG neurons were either IB4- or TrkA-positive. Of the small neurons 
(diameter <30 µm), a similarly high proportion of IB4-positive and TrkA-positive were 
Kv7.5-positive neurons (Table 2-2). In contrast, all of the large diameter, Kv7.2-positive 
neurons were IB4-negative, and a few were TrkA-positive. Taken together, these data 
show that Kv7.5 is mainly expressed by small diameter neurons. 
Peripheral axons of cutaneous nociceptors express Kv7.5 
Because Kv7 channel enhancers have local effects in the skin (Passmore et al., 
2003), we wished to determine whether cutaneous afferents express Kv7.5. We immuno-
stained unfixed sections of glabrous and hairy skin from rats for Kv7.2 or Kv7.5 and 
panNav. As shown in Figure 2-14, the panNav-positive unmyelinated axons were 
predominately Kv7.5-positive, and almost all were Kv7.2-negative. Pre-incubation of 
Kv7.5 antiserum with its cognate antigen greatly diminished the labeling of unmyelinated 
axons (Figure 2-15). 
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DISCUSSION 
In this present study, we found that C-fibers, including their cutaneous branches, 
express Kv7.5 and not Kv7.2 or Kv7.3. Small diameter DRG neurons also preferentially 
express Kv7.5 along with either IB4 or TrkA. Thus, Kv7.5 is the predominant Kv7 
channel expressed by nociceptors, from their cell bodies to their terminals. In contrast to 
Kv7.2 and Kv7.3, Kv7.5 expression was not found at nodes of Ranvier. Although Kv7.5 
subunits can form heteromeric channels with the Kv7.3 subunits (Schroeder et al., 2000), 
Kv7.3 was not co-localized with Kv7.5 in C-fibers, suggesting that the Kv7.5 forms 
homomeric channels in C-fibers. 
Although a previous study found that cultured DRG neurons express Kv7.2, 
Kv7.3, and/or Kv7.5 (Passmore et al., 2003), the authors did not emphasize that Kv7.5 is 
mainly localized to small diameter neurons as we report here. However, they did show 
that the M-current was the dominant subthreshold sustained current in small sensory 
neurons, and that many were capsaicin-sensitive, confirming that they are nociceptors 
(Passmore et al., 2003). This observation is in agreement with our finding that the Kv7.5-
positive small diameter DRG neurons are also positive for either IB4 or TrkA, both 
neurochemical markers of nociceptors. Interestingly, several studies of nerve function 
suggest that C-fibers and their terminals are refractory to the M-channel blocker XE991 
(Lang et al., 2008, Roza and Lopez-Garcia, 2008), while A-fibers are sensitive to 
inhibition (Schwarz et al., 2006, Brown and Passmore, 2009). Since the IC50 for XE991 
inhibition is much higher for Kv7.5 (50-70μM; Schroeder et al. (2000)) than it is for 
Kv7.2/7.3 subunits (0.6μM; Wang et al. (2000)), the preferential expression of Kv7.5 by 
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C-fibers may explain its insensitivity to XE991. Large neurons, in contrast, were IB4-
negative and Kv7.2-positive, consistent with a previous study showing that IB4-negative 
neurons had a TEA-sensitive Kv current (with properties of slow kinetics and no 
inactivation) that was inhibited by 25 mM TEA (Vydyanathan et al., 2005), which should 
block Kv7.2 but not Kv7.5 (Hadley et al., 2000, Schroeder et al., 2000, Hadley et al., 
2003). Our results contradict a recent report that Kv7.2-immunoreactivity is 
predominately localized to small sensory neurons and abundantly expressed in sciatic 
nerve axons (Rose et al., 2011). These findings are at odds with several reports that 
Kv7.2 is localized to nodes (Devaux et al., 2004, Pan et al., 2006, Schwarz et al., 2006) 
and our finding that large and not small sensory neurons are Kv7.2-positive. We have, 
furthermore, found that Kv7.2-immunoreactivity is lost in both nodes and large diameter 
DRG neurons from a Kv7.2-conditional null mouse (chapter 3), demonstrating the 
authenticity of our results. Taken together, different populations of sensory neurons 
express different levels of Kv7.2 and Kv7.5 (and likely Kv7.3); these channels likely 
affect their electrophysiological characteristics, akin to the differential expression of 
different voltage-gated Na channels in different kinds of sensory neurons (Waxman et al., 
1999). 
Whether Kv7.5 functions in the conduction of normal C-fibers remains uncertain. 
Devaux et al. (2004) showed that retigabine [a Kv7-specific enhancer (Lerche et al., 
2000, Brueggemann et al., 2007)] mildly slows the conduction velocity of myelinated 
axons; they did not investigate C-fibers. In biopsied human sural nerves, retigabine 
increased the membrane threshold and modified the post spike recovery cycle of C-fibers 
(Lang et al., 2008), but these nerves were recovered from patients suffering from 
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neuropathy or peripheral vascular disease. However, Roza and Lopez-Garcia (2008) 
reported that retigabine had no effect on C-fiber conduction in mouse saphenous nerve, 
but they only used one type of stimulus (a von Frey probe) and had a small sample size (5 
units). These results are not definitive in our opinion. 
In contrast, Kv7 enhancers have substantial effects in rodent models of 
neuropathic/inflammatory pain. Kv7 enhancers (retigabine or flupirtine) reduce the 
excitability of injured axons to both mechanical and chemical stimuli (Passmore et al., 
2003, Roza and Lopez-Garcia, 2008), as well as the behavioral responses of rodents 
following nerve ligation or cutaneous injections of irritants (Blackburn-Munro and 
Jensen, 2003, Passmore et al., 2003, Dost et al., 2004, Nielsen et al., 2004). Because these 
effects can be blocked by co-administrating Kv7 blockers, they most likely stem from 
enhanced Kv7 activity. Our finding that Kv7.5 is the main Kv7 subunit expressed by C-
fibers, focuses attention on the possible role of Kv7.5 in these models of pain, and the 
expression of Kv7.5 during the development of neuropathic pain warrants further 
investigation. 
The ability of G-protein-coupled receptors (GPCRs) to modulate Kv7 channels 
gives rise to the possibility that GPCRs expressed by nociceptive axons modulate 
neuropathic/inflammatory pain. Local injection of inflammatory mediators that bind to 
GPCRs, such as bradykinin and certain proteases, can cause pain, presumably through the 
excitation and sensitization of the peripheral terminals of nociceptors (Linley et al., 
2010). In small cultured DRG neurons, bradykinin (via the B2R receptor) increases 
intracellular Ca2+, which inhibits M-currents (Liu et al., 2010); in vitro study using CHO 
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cells specifically shows intracellular Ca2+ only inhibits Kv7.2, Kv7.4, and Kv7.5 subunits 
(Gamper et al., 2005). Furthermore, injecting bradykinin into rat hind paws produced 
nocifensive behavior that is reversed by retigabine, suggesting that bradykinin induces 
acute pain, at least in part, through its modulation of Kv7 channels (Liu et al., 2010). 
Similarly, ligands for protease-activated receptor 2 (PAR-2) inhibit M-current in small 
cultured DRG neurons by increasing intracellular Ca2+ (Linley et al., 2008). Injecting 
PAR-2 agonists into rat hind paws produce nocifensive behavior similar to that produced 
by Kv7 blocker (XE991) injection, and the simultaneous injection of both compounds 
does not produce additive pain response, indicating that PAR-2 agonists act primarily 
through the Kv7 channels. Finally, beta-alanine, the ligand for MrgD receptors, inhibits 
the M-current in cultured IB4-positive sensory neurons (Crozier et al., 2007); the 
electrophysiological effects of beta-alanine are absent in Mrgprd-null sensory neurons, 
but the M-current was not measured (Rau et al., 2009). Taken together, the endogenous 
ligands of GPCRs may decrease the M-current of nociceptors, which we have reason to 
believe is largely generated by Kv7.5 channels, and lead to increased nociception. 
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Figure 2-1 
 
 
Figure 2-1: Primary structure of Kv7.2 and Kv7.5 (Rattus norvegicus).  
The first 120 amino acids of Kv7.2 (NCBI Reference Sequence: NP_001153611.1) and 
Kv7.5 (NCBI Reference Sequence: NP_034741.2) are aligned with NCBI COBALT. 
Residues that are identical between Kv7.2 and Kv7.5 are shown in bold. The sequences 
targeted by the Chemicon AB5599 antibody are highlighted in blue (Caminos et al., 
2007), while the immunogen for the Chemicon AB9792 antibody is highlighted in yellow 
(information from Chemicon). The region common between the two antibodies is shown 
on a green background.  
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Figure 2-2 
 
 25 
Figure 2-2: Remak bundles, but not nodes, express Kv7.5.  
These are digital images of unfixed teased fibers, double-labeled for either Kv7.2 or 
Kv7.5 (Chemicon AB9792; red) and voltage-gated sodium channels (panNav; green). In 
column A, note that Kv7.2 and panNav are co-localized at nodes (arrows), but Kv7.2 is 
not localized in a Remak bundle (arrowhead). In column B, Kv7.5 is not detected at 
nodes (arrows), but is expressed in a Remak bundle (arrowhead), and as a granular 
staining on myelinated axons (chevrons). Scale bar: 10 µm. 
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Figure 2-3 
 
Figure 2-3: Remak bundles do not express Kv7.3. 
These are digital images of unfixed mouse teased nerves, double-labeled for either Kv7.2, 
Kv7.3, or Kv7.5 (AB5599; red) and voltage-gated sodium channels (panNav; green). In 
columns A and B, note that Kv7.2 and Kv7.3 are co-localized with panNav at nodes 
(arrows), but not in Remak bundles (arrowheads). In column C, the Kv7.5 antiserum 
labels Remak bundles (arrowheads) but not nodes (arrow). Scale bar: 10 µm. 
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Figure 2-4 
 
Figure 2-4: Granular staining of myelin sheaths with the AB9792 Kv7.5 antiserum.  
These are unfixed teased fibers, double-labeled for Kv7.5 (red) and panNav (green), 
neurofilament heavy (NFH, red), or myelin-associated glycoprotein (MAG, red), as 
indicated. Note that the granular staining is associated with myelinated axons (chevrons), 
as shown by the their co-localization with MAG, but not with axons (NFH staining) or 
Remak bundles (arrowheads). The arrows indicate a node. Scale bar 10 µm. 
  
 28 
Figure 2-5 
 
Figure 2-5: AB5599 and AB9792 antisera recognize Kv7.5 but not Kv7.2.  
These are images of HeLa cells transiently transfected to express human Kv7.2 or Kv7.5, 
labeled with the indicated antiserum and counterstained with DAPI. Note that the Kv7.2 
antiserum (A) labels cells expressing Kv7.2 and not Kv7.5, and that the AB5599 (B) and 
AB9792 (C) antisera label cells expressing Kv7.5 but not Kv7.2. Scale bar: 20 µm. 
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Figure 2-6 
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Figure 2-6: Axotomy abolishes Kv7.5 expression.  
These are digital images of unfixed rat teased fibers, taken from the nerve segment distal 
to the lesion (columns B and D) 4 days post-transection, or the corresponding segment of 
an unlesioned nerve (columns A and C). The fibers were double-labeled for Kv7.5 
(Chemicon AB9792; green) and either voltage-gated sodium channels (panNav; red) or 
glial fibrillary acidic protein (GFAP; red, labels Remak Schwann cells), and 
counterstained with DAPI to visualize nuclei (blue). Note that panNav-immunoreactivity 
is associated with nodes (arrows) and a Remak bundle (arrowhead), which is lost after 
axotomy (columns A and B), and that Kv7.5-immunoreactivity in Remak bundles 
(arrowheads) is lost after axotomy, whereas GFAP-immunoreactivity persists. Scale bar: 
20 µm. 
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Figure 2-7 
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Figure 2-7: Cognate antigen reduces immunostaining of Remak bundles with Kv7.5 
antiserum AB9792.  
These are images of unfixed teased fibers that were double-labeled for Kv7.5 (AB9792; 
red) and panNav (green), as indicated. The images were exposed for the same amount of 
time to facilitate direct comparison. Compared to teased fibers labeled with the AB9792 
antiserum alone (column A), pre-incubation with the control antigen (column B) reduced 
the granular staining of myelinated axons (chevrons) and abolished the staining of Remak 
bundles (arrowheads), which are also labeled by the panNav antibody. Arrows indicate 
nodes. Scale bar: 10 µm. 
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Figure 2-8 
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Figure 2-8: RT-PCR expression analysis of rat sciatic nerve and DRG RNA.  
Total RNA was isolated from adult rat tissues, duplicate samples were subjected to RT-
PCR with the indicated primers and polymerases, and the reaction products were 
separated by gel electrophoresis. A ~200 bp band, corresponding to the predicted size of 
the Kv7.5 mRNA sequence, was detected in both the DRG and the sciatic nerve RNA 
samples. When PCR polymerase is used instead of RT-PCR polymerase, the Kv7.5 
primers did not amplify a similarly sized product from the RNA samples, indicating that 
they were not contaminated by genomic DNA. A ~370 bp band, corresponding to the 
predicted size of MAG mRNA, was present in both RNA samples. Molecular markers are 
located in the first and last lanes (in 100 bps). 
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Figure 2-9 
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Figure 2-9: Kv7.5 is predominately expressed by the small DRG neurons.  
These are images of unfixed sections of rat lumbar DRG, double-labeled with rabbit 
antisera (magenta) against Kv7.2 or Kv7.5 (AB9792) and a panNav monoclonal antibody 
(green). Note that in column A, the Kv7.2 antiserum predominately labels large diameter 
neurons (two examples denoted with arrowheads), which are relatively unlabeled by the 
panNav antibody. In contrast, in column B, the Kv7.5 antiserum and the panNav antibody 
preferentially label small diameter neurons (two examples denoted with arrows). Scale 
bar: 20 µm. 
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Figure 2-10 
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Figure 2-10: Stem processes are Kv7.5-negative. 
These are images of unfixed sections of rat lumbar DRG, double-labeled with rabbit 
antisera (red) against Kv7.2 or Kv7.5 (AB9792) and a panNav monoclonal antibody 
(green). In column A, note that Kv7.2 and panNav are co-localized in a stem process 
(chevron). In column B, the Kv7.5 antiserum does not label the stem process, which is 
panNav-positive (chevron). Scale bar: 20 µm. 
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Figure 2-11 
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Figure 2-11: Smaller DRG neurons express relatively higher levels of Kv7.5. 
The level of Kv7.5/AB9792-immunoreactivity was measured in sections from lumbar 
DRG neurons from 3 adult rats. Note that Kv7.5-immunoreactivity is inversely related to 
the size of the DRG neurons, with the majority of the labeled cells (fluorescence intensity 
>20) being small [cell diameter less than 30 µm, or 701 µm2 (Rasband et al., 2001). The 
slope of the inverse relationship for each rat is statistically different as compared to the 
slope of no relationship (slope of 0), with a p value of < 0.05 (Student’s t-test). 
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Figure 2-12 
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Figure 2-12: Cognate antigen blocks immunostaining of DRG neurons with Kv7.5 
antiserum AB9792.  
These are images of sections of unfixed rat DRG, double-labeled for Kv7.5 (AB9792; 
red) and panNav (green), as indicated. The images were exposed for the same amount of 
time to facilitate direct comparison. Pre-incubation with the control antigen (column B) 
reduced the neuronal staining of the AB9792 antiserum. Scale bar: 20 µm. 
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Figure 2-13 
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Figure 2-13: Kv7.5-positive DRG neurons are mostly IB4- or TrkA-positive.  
These are images of unfixed sections of rat DRG, triple-labeled as indicated for either 
Kv7.5 (AB9792; red) or Kv7.2 (red), as well as IB4 (green) and TrkA (blue). Note that 
most Kv7.5-positive neurons are IB4-positive (arrows); fewer are TrkA-positive 
(arrowheads). In contrast, none of the Kv7.2-positive neurons are IB4-positive (arrow), 
but some are TrkA-positive (arrowheads); all of the IB4-positive neurons are Kv7.2-
negative (chevrons). Scale bar: 20 µm. 
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Figure 2-14 
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Figure 2-14: Cutaneous afferents express Kv7.5.  
These are digital images of unfixed section of hairy skin, double-labeled for Kv7.2 (red), 
Kv7.5 (Chemicon AB9792; magenta), and voltage-gated sodium channels (panNav; 
green). In column A, the unmyelinated axons are labeled by the panNav antibody but not 
by the Kv7.2 antiserum (one example is denoted with an arrowhead). In column B, the 
unmyelinated axons are labeled by both the Kv7.5 antiserum and the panNav antibody 
(arrowhead). Scale bar: 20 µm. 
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Figure 2-15 
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Figure 2-15: Cognate antigen blocks immunostaining of cutaneous afferents with 
Kv7.5 antiserum AB9792.  
These are images of sections of unfixed hairy skin, double-labeled for Kv7.5 (AB9792; 
green) and glial fibrillary acid protein (GFAP; a marker of non-myelinating Schwann 
cells; red), as indicated. The images were exposed for the same amount of time to 
facilitate direct comparison. Compared to rat skin labeled with the AB9792 antiserum 
alone (column A), pre-incubation with the control antigen (column B) reduced the 
staining of cutaneous afferents (arrowheads), but not the GFAP-staining of their 
associated Schwann cells. The pre-incubation also diminished Kv7.5-immunoreactivity 
of the stratum basale (chevron). Scale bar: 20 µm. 
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Table 2-1 
 
 
Table 2-1: List of Primary Antibodies Used 
  
Name Manufacturer Dilution Species Type Immunogen 
KCNQ2
N 
A gift from Dr. 
Edward 
Cooper 
1:200 Rabbit Polyclonal KCNQ2 N-terminus 
(residues 13-37) 
KCNQ3
C 
A gift from Dr. 
Edward 
Cooper 
1:200 Rabbit Polyclonal KCNQ3 C-terminus (residues 
578-604) 
KCNQ5 Chemicon; 
AB5599 
1:1000 Rabbit Polyclonal KCNQ5 N-terminus 
(residues 12-93)  
Kv7.5 Chemicon; 
AB9792 
1:200 Rabbit Polyclonal KCNQ5 N-terminus 
(residues 89-103) 
panNav Sigma; clone 
K58/35 
1:250 Mouse Monoclonal CTEEQKKYYNAMKKLGS
KK from the intracellular III-
IV loop of Na+ channels 
TrkA R&D Systems; 
AF1056 
1:100 Goat Polyclonal Recombinant rat TrkA 
(Ala33Pro418) 
IB4 Sigma; L2140 1:100 Biotin-
conjugated 
N/A Major affinity for terminal α-
D-galactosyl residues of 
blood group B 
MAG R&D Systems; 
AF538 
1:100 Goat Polyclonal Recombinant rat MAG 
extracellular domain 
(rrMAG) 
NF-H A gift from Dr. 
Virginia Lee 
1:500 Rat Monoclonal Clone Ta51; bovine 
neurofilament-heavy subunit 
GFAP A gift from Dr. 
Virginia Lee 
1:200 Rat Monoclonal Highly enriched glial 
filament proteins from bovine 
spinal cord 
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Table 2-2 
 
  IB4-positive only TrkA-positive only Total Neurons 
 
Rat #1  12/17 (70.6%)  5/6 (83.3%)  17/23 (73.9%) 
 
Rat #2  17/21 (81.0%)  9/9 (100%)  23/30 (76.7%) 
 
Rat #3  17/20 (85.0%)  8/10 (80%)  25/30 (83.3%) 
 
 
Table 2-2: A high proportion of small, IB4- and TrkA-positive neurons are Kv7.5-
positive. 
The cell soma size as well as the fluorescence intensity of IB4, TrkA, and Kv7.5 was 
measured for ~100 DRG neurons from 3 rats. For each rat, we counted the number of 
small neurons (diameter < 30 µm) that were either IB4- or TrkA-positive (fluorescence 
intensity >20), and also determined whether they were Kv7.5-positive. For each rat, the 
fraction of Kv7.5-positive small neurons to the total number small DRG neurons is 
shown. A similarly high proportion of IB4-positive and TrkA-positive small neurons are 
Kv7.5-positive.  
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CHAPTER 3: IMMUNOHISTOCHEMICAL, BEHAVIORAL, AND 
ELECTROPHYSIOLOGICAL ANALYSIS OF Kcnq2-NULL PERIPHERAL 
SENSORY MYELINATED AXONS 
 
INTRODUCTION 
The Kv7 (KCNQ) family of K+ channels is made up of five members, Kv7.1 to Kv7.5 
(Jentsch, 2000, Delmas and Brown, 2005, Brown and Passmore, 2009). While many PNS 
and CNS neurons have been shown to express Kv7.2, Kv7.3, and K7.5, recently Kv7.1 
and Kv7.4 have also been found in certain neuronal populations (Goldman et al., 2009, 
Heidenreich et al., 2011). In addition, Kv7.1 and Kv7.4 are prominently expressed in the 
cochlea, and Kv7.1 is expressed in the heart (Brown and Passmore, 2009). Kv7 channels 
contribute to the normal resting membrane potential, and also form the non-inactivating 
M-current, because muscarinic agonists  modulation it (Brown and Adams, 1980, Wang 
et al., 1998). Their importance in maintaining normal cellular excitability is demonstrated 
by the effects of dominant mutations of KCNQ1, KCNQ2, KCNQ3, and KCNQ4 – all 
decrease the Kv7 current and cause hereditary diseases in a cell autonomous manner 
(Singh et al., 1998) - in the heart (KCNQ1), brain (KCNQ2 and KCNQ3), and inner ear 
(KCNQ1 and KCNQ4) (Jentsch, 2000, Brown and Passmore, 2009). One KCNQ2 
mutation causes neuromyotonia (Dedek et al., 2001), which is likely the result of 
diminished Kv7.2 and Kv7.3 current at nodes of Ranvier, where Kv7.2 and Kv7.3 are 
localized (Devaux et al., 2004). A conserved ankyrin-G binding motif located at the C-
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termini mediates the localization of Kv7.2 and Kv7.3 at nodes and axon initial segments 
(Pan et al., 2006).  
Previous investigations of the role of Kv7 in regulating neuronal excitability and 
nociceptive behaviors utilized pharmacological M-channel blockers and/or enhancers 
(Passmore et al., 2003, Yue and Yaari, 2004, Rivera-Arconada and Lopez-Garcia, 2006, 
Lang et al., 2008, Roza and Lopez-Garcia, 2008). Because homozygous Kcnq2-null mice 
die at birth due to pulmonary atelectasis, investigators studied heterozygous Kcnq2-
knockout mice (Watanabe et al., 2000, Yang et al., 2003, Otto et al., 2006, Tzingounis 
and Nicoll, 2008), Kcnq3-null mice (Tzingounis and Nicoll, 2008), or mice expressing a 
dominate negative mutant allele of human KCNQ2 as a transgene (Peters et al., 2005). 
None of these studies, however, satisfy the need to develop an animal model with a 
complete absence of Kv7.2 expression. In addition, previous studies of heterozygous 
Kcnq2-knockout mice found that reduction of Kv7.2 expression can lead to decreased 
seizure threshold (Watanabe et al., 2000, Yang et al., 2003). 
 In the present study, we characterize mice in which Kcnq2 has been deleted in all 
somatic sensory neurons, using the Cre-Lox system (Sauer and Henderson, 1988, Nagy, 
2000). These mice are viable and their myelinated sensory axons have a normal 
ultrastructure and normal molecular composition of nodes (including Kv7.3), paranodes, 
and juxtaparanodes. Kcnq2 mutant mice showed increased signs of thermal hyperalgesia 
and mechanical allodynia, and Kcnq2-null dorsal root ganglia (DRG) neurons showed 
increased excitability and reduced spike-frequency adaptation. Taken together, our results 
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suggest that Kv7.2 regulates neuronal excitability, and a reduction of Kv7.2 expression 
could lead to altered nociception. 
 
MATERIALS AND METHODS 
All procedures involving rodents were approved by the Institutional Animal Care and 
Use Committee of the University of Pennsylvania. Except when specified, all chemicals 
were from Sigma. 
Generation of conditional Kcnq2-null mice 
A floxed allele of Kcnq2 was designed (Fig. 1A) to delete exons 3-5; these correspond to 
463 bp (amino acid 130-285) of mouse Kcnq2 cDNA (GeneBank AF490773; (Wen and 
Levitan, 2002); this deletion has been shown to result in a functional null allele 
(Watanabe et al., 2000). Two DNA fragments (EcoRV and Xhol) were cloned from R1 
ES-cells genomic DNA, and used to generate a targeting vector in which a FRT-
neomycin-FRT-loxP cassette was inserted into a unique Xhol site, with flanking 7kb and 
3.4kb of homologous genomic DNA. An additional loxP site was inserted in an EcoRI 
site just upstream of the third exon. The targeting vector also includes a diphtheria toxin 
(DT) gene as a negative selection marker against ES clones which have randomly 
integrated the targeting vector. The linearized targeting vector was electroporated into R1 
embryonic stem cells, selected with G418, and colonies were picked and analyzed by 
duplication. Positive ES cells were used to first generate chimeras and then heterozygous 
mice (Gollan et al., 2003, Poliak et al., 2003). The presence of the targeted locus was 
confirmed by PCR analysis of tail DNA. Heterozygous mice were first mated with mice 
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carrying the FLP recombinase (129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J; 
(Farley et al., 2000), to remove the Neo cassette and to create a floxed Kcnq2 allele.  
We crossed mice expressing Pax3-Cre (Jackson Laboratory; stock number 
005549) with mice carrying the Rosa26 reporter gene (Jackson Laboratory; stock number 
003504). We examined X-gal expression in the brains, spinal cords, and lumbar DRG of 
3 Pax3-Cre-positive // Rosa26 mice and 3 Pax3-Cre-negative // Rosa26 littermates, all 1-
month-old, as previously described (Feltri et al., 1992, Arroyo et al., 1998). The mice 
were perfused with 0.5% glutaraldehyde (in 0.1M PB, pH 7.4), their cerebra, cerebelli, 
and spinal cords were dissected and cut into slabs with a razor blade, and the resulting 
sections along with L4 and L5 DRG were fixed for 3 hours at 4oC, stained in X-Gal 
(Roche Diagnostic) at 370C for 24-48 hours, rinsed in 0.1M PB, then re-fixed in 3% 
glutaraldehyde (in 0.1M PB) at 4oC overnight. The samples were photographed using a 
Nikon Coolpix 5000 camera mounted on a Leica MZ16 FA stereomicroscope. The DRG 
were osmicated, dehydrated, and embedded with the Embed 812 kit (EMS). Semi-thin 
sections (1 μm thick) were photographed using a cooled Hamamatsu camera mounted on 
Leica DMR light microscope. 
Kcnq2 was deleted in sensory axons by crossing with mice that were 
heterozygous for both the floxed Kcnq2 allele and Pax3-Cre (Kcnq2f/+ // Pax3-Cre). We 
chose this approach because it generates relatively mice of the desired genotype, and 
homozygous Pax3-Cre mice fail to develop past E18.5 according to Jackson Laboratory. 
All offspring were genotyped by PCR. Tail DNA was digested with DirectPCR (Viagen) 
and proteinase K overnight at 55oC, heated to 85oC for 45 minutes to denature proteinase 
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K, then PCR were then performed with REDTaq ReadyMix PCR reaction mix following 
manufacturer’s protocol in a Bio-Rad DNA Engine peltier thermal cycler. Three primers 
were used together: KCNQ2A (GGGGCAGTTGTCTAACCCTC), KCNQ2C 
(TATGTGGTGCTCCCCAGAAG), and KCNQ2E (GGGAGGCTCTAGTGTCAGTG); 
see Figure 1B. After amplification, samples were separated in 1.5% agarose (GeneMate) 
gel in 1xTBS at 125V for 1 hour. 
 
Anatomical studies 
One-month-old Kcnq2-mutant mice (Kcnq2fl/fl // Pax3-Cre; n=3) and their control 
littermates (Kcnq2+/+ // Pax3-Cre; n=3) were anesthetized with ketamine/xylazine mix 
and killed by decapitation. Sciatic nerves, dorsal root ganglia (from L4-L6 spinal levels) 
with the ventral and dorsal roots attached, and femoral nerves (motor and sensory 
branches separately) were dissected, and quickly embedded in OCT cooled in an 
acetone/dry ice slurry. The sciatic and femoral nerve fibers were teased apart with fine 
needles, mounted on SuperFrost Plus glass slides (Fisher Scientific, Pittsburgh, PA), 
dried overnight, and stored at -20oC. Ten µm thick cryostat sections were thaw-mounted 
onto SuperFrost slides, and stored at -20oC. Teased fibers and OCT sections were 
immersed in -20oC acetone for 10 minutes, rinsed in Tris-buffered saline (TBS; pH 7.4), 
blocked at room temperature for one hour in TBS containing 5% fish skin gelatin and 
0.5% Triton X-100, and incubated overnight at 4oC with various combination of primary 
antibodies diluted in blocking solution - a rabbit antiserum against a peptide from the N-
terminus of Kv7.2 (KCNQ2N, 1:200 (Cooper et al., 2001) or a rabbit antiserum against a 
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peptide from the C-terminus of Kv7.3 (KCNQ3C, 1:200 (Pan et al., 2006), combined 
with a mouse monoclonal antibody either against all voltage-gated Na+ channels 
(panNav; Sigma clone K58/35, 1:250), Kv1.1 (NeuroMab clone K20/78, 1:200), or 
contactin-associated protein (Caspr; clone 2751:100 (Poliak et al., 1999). The slides were 
washed with TBS, incubated with the appropriate FITC- and TRITC-conjugated donkey 
cross-affinity-purified secondary antibodies (Jackson ImmunoResearch, 1:200) at room 
temperature for one hour, washed with TBS, counterstained with 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Invitrogen), mounted with Vectashield (Vector 
Laboratories), then examined with a Leica DMR light microscope with a cooled 
Hamamatsu camera under the control of Openlab software (Openlab, Improvision). 
 To ascertain the specificity of the Kv7.2 antisera, Hela cells were transiently 
transfected with the cDNA encoding human Kv7.2 or Kv7.3, (kindly provided by Dr. 
Edward Cooper) using the Lipofectamine 2000 (Invitrogen) method as previously 
described (Rasmussen et al., 2007), and immunostained 1 day post-transfection with the 
Kv7.2 (gifts of Drs. Edward Cooper and Jérôme Devaux) and Kv7.3 (gift of Dr. Edward 
Cooper) antisera. 
 To analyze the structure of myelinated axons, one-month-old Kcnq2 mutant mice 
(Kcnq2fl/fl // Pax3-Cre; n=3) and littermates controls (Kcnq2+/+ // Pax3-Cre; n=3) were 
perfused with 2% glutaraldehyde/2% paraformaldehyde mix (in 0.1M PB) for 10 
minutes, then the femoral sensory and motor branches as well as the L4 and L5 DRG 
were dissected, fixed for 4 hours at 4oC, osmicated, dehydrated, and embedded with the 
Embed 812 kit. Semi-thin (1 μm) sections were stained with toluidine blue and examined 
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as above; thin (80 nm thick) sections were stained with lead citrate and examined with a 
JEM-1010 transmission electron microscope (JEOL USA) outfitted with a digital camera.  
 
Behavior Testing 
Three-month-old Kcnq2-mutant mice (Kcnq2fl/fl // Pax3-Cre; n=9) and their littermates 
(Kcnq2+/+ // Pax3-Cre; n=9), derived from 3 litters were studied. Mechanical allodynia 
was measured using Chaplan’s up-down threshold method (Chaplan et al., 1994, Hubbard 
and Winkelstein, 2005, Lee et al., 2008, Quinn et al., 2010). Mice were confined in 
plexiglass enclosure placed on a wire-mesh platform and allowed to acclimate for at least 
30 minutes before each test. Three rounds of testing was performed over three 
consecutive days, with each round comprised of five stimulations of either the right or the 
left mid-plantar hindpaw in a random order, with a series of ascending von Frey filament 
strength (0.4 g, 0.6 g, 1.0 g, 1.4 g, 2.0 g; Stoelting Co.) held perpendicular for 8-10 
seconds with enough force to cause slightly buckling against the skin. A positive 
response is recorded for sharp paw withdrawal or if immediate flinching was observed 
upon removal of filament. If two consecutive filament strengths elicited a withdrawal 
response, the lower of the two filament strengths was recorded as the threshold. Any 
mouse that failed to display a response with the highest filament strength was recorded as 
having a threshold of 2.0 g. Testing in the opposite direction (descending filament 
strength) was also performed during each round to confirm the withdrawal threshold. The 
average threshold of the three rounds was recorded for each mouse. 
Thermal nociceptive response was assessed using a paw thermal stimulator 
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system (UARDG, University of California San Diego; otherwise referred to as 
Hargreaves’ apparatus) as previously described (Hargreaves et al., 1988, Dirig et al., 
1997). Four rounds were performed over four consecutive days. Briefly, the mice were 
allowed to acclimate on the glass plate of the apparatus (maintained at 30oC) for at least 
30 minutes, then either the left or the right mid-plantar hindpaw was randomly heated 
with a thermocouple set at 5 amperes. A timer is automatically started with the thermal 
source, and response latency is defined as the time required for the hindpaw to show an 
abrupt withdrawal (maximum 20 seconds). Paw withdrawal is automatically detected by 
an array of photodiode motion sensors mounted on the stimulus tower that stops the timer 
and terminates the stimulus. Stimulus current is monitored continuously. Six trials were 
performed during each round, with a minimum of 5 minutes between each trial to allow 
the hindpaws to return to normothermic baseline (Dirig et al., 1997). The average 
threshold of the four rounds was recorded for each mouse. 
Motor function was measured with a rotarod apparatus (Ugo Basile, Stoelting 
Co.) as previously described (Wood et al., 2005, Oliveira et al., 2006). Briefly, the 
rotarod has a 3-cm diameter rotating rod raised 16 cm above a platform and divided into 
five sections for testing multiple mice simultaneously. Mice were acclimated on the first 
day by allowing them to run on the rotarod with the slowest rotation speed. Three rounds 
of testing were performed during the three subsequent days, with three trials during each 
round. For each trial, mice were placed on the rotarod, and the rotation speed was 
gradually increased from 4 to 40 rpm over the course of 5 minutes. Each trial ended when 
mice fell off (maximum 300 seconds), and the latency to fall was recorded for each trial. 
Test was considered valid if mice ran forward on the rotarod for at least 10 seconds. Mice 
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were given 1-hour rest between each trial. The average time to fall of each mouse was 
used as the outcome. 
 
Whole cell patch recording  
DRG neurons were dissected and cultured from three-month-old Kcnq2 mutant mice 
(Kcnq2fl/fl // Pax3-Cre; n=5) and their littermate controls (Kcnq2+/+ // Pax3-Cre; n=5) 
from 2 litters, as previously described (Malin et al., 2007). Lumbar DRGs were rapidly 
removed, transferred to ice-cold Ca2+/Mg2+-free HBSS (GIBCO), then incubated first in 
papain solution (60U papain; Worthington), 3μl saturated NaHCO3, 1 mg L-Cys free 
base, 1.5ml Ca2+/Mg2+-free HBSS (GIBCO) for 10 minutes at 37oC, then in 
collagenase/dispase solution (0.1U/ml collagenase 0.8U/ml dispase (Roche), 3 ml 
Ca2+/Mg2+-free HBSS) for 1 hour at 37oC. Neurons were dissociated by trituration using 
fire-polished glass Pasteur pipettes, suspended in F12 medium (GIBCO) containing 10% 
FCS (Invitrogen) and 1% penicillin/streptomycin (Invitrogen), then plated onto laminin 
/poly-D-lysine (Beckton Dickson) coated coverslips (Fisher). DRG neurons adhered to 
coverslips and were maintained in culture for 12-48 hours after plating at 37oC prior to 
recording. 
Whole cell patch-clamp techniques (Hamill et al., 1981, Lancaster et al., 2001) 
were employed with an Axopatch 200B amplifier and PCLAMP 9 software (Axon 
Instruments). Patch pipettes (1–4 MΩ) were fabricated from glass capillaries 
(MTW150F-4, World Precision Instruments). Pipettes were filled with a variant of a 
solution described previously (Ikeda et al., 1986), with a composition of (in mM) 140 
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KCl, 2 MgATP, 10 N-[2-hydroxyethyl] piperazine-N9-[2-ethanesulfonic acid] (HEPES), 
11 ethylene glycolbis(b-aminoethyl ether)-N,N,N9,N9-tetraacetic acid (EGTA), and 2 
CaCl2; titrated to pH 7.3 with KOH, and to 314 mOsm with sucrose. Pipette voltage 
offset was neutralized prior to the formation of a giga-seal. Membrane input resistance 
(Rin), series resistance (Rs), and capacitance (Cm) were determined from current transients 
elicited by 5 mV depolarizing steps from a holding potential of -60 mV, delivered using 
the Membrane Test application of PCLAMP9. Criteria for cell inclusion in the study were 
as follows: Rs ≤ 10 MV, Rm ≥ 100 MV, and stable recording during the entire experiment. 
Cover slips were superfused (2–4 ml/min) continuously during recording at 34–36°C 
extracellular solution (composition in mM: 10 glucose, 140 NaCl, 3 KCl, 0.6 MgCl2, 2.5 
CaCl2, 10 HEPES, titrated to pH 7.4 with TRIS base, to 325 mOsm with sucrose if 
needed). Tetraethylammonium (TEA) was fully dissolved in the extracellular solution 
prior to application; 3 mM TEA was applied for at least 2 minutes before determining its 
effects on membrane properties. To prevent bias in cell selection or analysis, the 
electrophysiologist was blinded to genotypes of the cells (control versus Kcnq2-null) 
during the experiments and measurements of cell properties. A total of 25 neurons from 
mutant mice, and 25 neurons from control littermates, were recorded and analyzed. 
 
Statistical Tests 
Other than the following exceptions, all comparisons between two samples were 
explored using unpaired two-samples Student’s t-test, with equal variance first 
established with the equality of variance test. All statistical tests were performed with 
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SAS 9.2 (SAS), with all data given as mean ± standard error of mean (SEM). Comparison 
of Kv7.2- and Kv7.3-positive nodes in different peripheral nerves was tested with two-
way ANOVA; motor function results over the course of nine sessions were analyzed with 
repeated measures ANOVA; two-way repeated measures ANOVA was used to compare 
mutant and control neurons before and after 3 mM TEA across multiple rheobase, 
followed by the Tukey test to identify specific significant differences. The minimum a 
priori criteria for statistical significance is p < 0.05. 
 
RESULTS 
Generation of conditional Kcnq2-null mice 
We generated mice lacking Kcnq2 expression in sensory neurons by using the 
Cre-Lox system (Sauer and Henderson, 1988, Nagy, 2000). Mice containing a floxed 
allele of Kcnq2 (Fig. 1A) were crossed with mice expressing a Pax3-Cre transgene, 
which is expressed by cells derived from the neural crest (Li et al., 2000). To determine 
whether Pax3-Cre deleted exons 3-5 of Kcnq2, we examined three Kcnq2fl/fl // Pax3-Cre 
mice by amplifying genomic DNA with PCR and appropriate primers (Fig. 3-1A). As 
shown in Figure 3-1C, while both the floxed and recombined Kcnq2 alleles were detected 
in the DRG and trigeminal ganglia, only the floxed allele was detected in the liver, 
indicating that the Kcnq2 allele was being selectively deleted in neural-crest-derived 
tissues. 
We examined the expression of the Pax3-Cre by crossing the mice with Rosa26 lacZ 
reporter mice, in which Cre removes a floxed stop cassette so that lacZ is expressed 
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(Soriano, 1999). Using litters that contained mice of the informative genotypes, we 
stained the brain, spinal cord, and DRG for beta-galactoside activity with X-gal as the 
chromogen. As shown in figure 3-2, none of the samples taken from any of the control 
animals showed X-gal staining. In contrast, a majority of the cerebellum, regions of the 
cerebrum (including the cortex, the hippocampus, the thalamus, and the hypothalamus), 
and the dorsal part of the spinal cord (including the dorsal roots) of Wnt1-Cre-positive 
mice were stained with X-gal. Pax3-Cre-positive mice also exhibited similar X-gal 
staining pattern (but with more intense thalamic staining and no detectable hippocampal 
or hypothalamic staining). Lastly, mice expressing Avil-Cre showed much less 
cerebellum X-gal labeling, with cerebrum staining primarily seen in the cortex and the 
hippocampus, as well as staining of the dorsal part of the spinal cord (including the dorsal 
roots). The ventral part of the spinal cords and the ventral roots from all three Cre lines 
were unstained, suggesting that motor neurons lack Cre expression. In contrast, as shown 
in figure 3-3, all DRG neurons from all three Cre lines showed X-gal staining, provide 
support that all DRG neurons were Wnt1-Cre-, Pax3-Cre, or Avil-Cre-positive. 
Interestingly, our observed pattern of Avil-Cre X-gal staining, especially within the 
cerebrum, was more extensive than had been previously described (Hasegawa et al., 
2007), but was more consistent with the Avil in situ hybridization data from the Allen 
Mouse Brain Atlas (experiment 69527692; Allen Mouse Brain Atlas), suggesting that 
Avil-Cre expression is not limited to sensory neurons. 
After analyzing the results of our X-gal experiment, we decided to use the Pax3-
Cre, which is expressed by cells derived from the neural crest (Li et al., 2000), including 
all sensory neurons (Toth, 1966). The Pax3-Cre mediated deletion of exons 3-5 of the 
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floxed Kcnq2 allele (figure 3-1, panel A), which resulted in a complete knockout of 
Kcnq2 expression in neural crest derived tissues. 
 
Primary sensory neurons in conditional Kcnq2-null mice lacked Kv7.2 
To determine whether Pax3-Cre resulted in the loss of Kv7.2 expression in 
sensory neurons, we examined three mutants (Kcnq2fl/fl // Pax3-Cre) and three control 
littermates (Kcnq2+/+ // Pax3-Cre). We immunostained unfixed teased nerve fibers from 
femoral sensory and motor branches, and from dorsal and ventral roots, as well as 
sections of the lumbar DRG, for Kv7.2 or Kv7.3, combined with a mouse monoclonal 
antibody against voltage-gated Na+ channels (panNav). As shown in figure 3-4, in the 
control mice, all nodes of Ranvier of both the motor and sensory branches of the femoral 
nerve were Kv7.2- and panNav-positive, agreeing with previously published results 
(Devaux et al., 2004, Pan et al., 2006). In mutant animals, all nodes were panNav-
positive, but none of the nodes of the femoral sensory branch, and only some nodes of the 
femoral motor branch, were Kv7.2-positive. The lack of nodal staining of the Kcnq2-null 
sensory axons supports for the specificity of the Kv7.2 antiserum, which also selectively 
labeled HeLa cells transiently transfected to express human Kv7.2, but did not label 
transfected cells expressing Kv7.3 (Fig. 3-5). Similarly, none of the nodes in the dorsal 
roots (which are purely sensory), and all of the nodes in the ventral roots (which are 
purely motor), were Kv7.2-positive (Fig. 3-7). Another Kv7.2 antiserum (provided by Dr. 
Jérôme Devaux) gave similar results (data not shown). 
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Because Kv7.3 can form heteromeric channels with Kv7.2 in vitro (Wang et al., 
1998, Selyanko et al., 2001, Shah et al., 2002, Maljevic et al., 2003), and Kv7.2 and 
Kv7.3 co-localize at nodes in vivo (Pan et al., 2006, Schwarz et al., 2006), we wish to 
investigated whether proper Kv7.3 nodal expression require Kv7.2. Unlike Kv7.2, both 
the femoral motor and sensory branches of mutant mice showed robust Kv7.3 
immunostaining at all nodes (Figure 3-6), indicating that proper Kv7.3 nodal expression 
does not require Kv7.2. Similarly, in the dorsal and ventral roots of mutant animals 
(Figure 3-7), Kv7.2 nodal staining is absent in the dorsal root and present in the ventral 
root, while Kv7.3 nodal staining is present at both dorsal and ventral roots. Notably, 
because the dorsal root is composed entirely of sensory axons, and the ventral root is 
predominately composed of motor axons (Karlsson and Hildebrand, 1993), the total 
absence of Kv7.2 immunostaining in the dorsal root coupled with the presence of Kv7.2 
staining in the ventral root provide strong evidence that Kcnq2 expression is being 
selectively knocked-out in the sensory neurons of our mutant animals. To quantify these 
results, we calculated the percentages of Kv7.2- or Kv7.3-positive nodes in each of the 
four nerve branches (femoral sensory, femoral motor, ventral root, and dorsal root) out of 
all panNav-positive nodes. As shown in figure 3-8, there were significant decreases in the 
percentage of Kv7.2-positive nodes in the dorsal root (1.43 ± 0.06%), femoral sensory 
branch (0.48 ± 0.48%), and femoral motor branch (47.13 ± 1.56%) of the mutant animals 
versus the wild-type littermates (99.45 ± 0.55%, 97.66 ± 0.53%, 96.36 ± 0.95% 
respectively). However, the percentage of Kv7.2-positive nodes in the ventral root is not 
different between the mutant animals (99.40 ± 0.60%) and the wild-type littermates 
(97.46 ± 0.41%), suggesting intact Kv7.2 expression in the motor neurons. In contrast, 
 65 
the percentages of Kv7.3-positive nodes in all four nerve branches were found to 
approach 100% in both mutant and wild-type mice. 
 After demonstrating intact nodal Kv7.3 and voltage-gated sodium channels 
expression, we wanted to study the molecular components of the paranodes and 
juxtaparanodes of the Kcnq2-null axons. Therefore we double-labeled the sciatic nerve of 
mutant mice for Kv7.2 and either panNav, Caspr, or Kv1.1 antibodies. As shown in 
figure 3-9, the selected nodal (panNav), paranodal (Caspr) and juxtaparanodal (Kv1.1) 
components are the same for myelinated axons for both Kv7.2-positive (motor axons) or 
Kv7.2-negative (sensory axons) nodes. Thus, the molecular components of nodes, 
paranodes, and juxtaparanodes appeared to be maintained in Kcnq2-null sensory axons. 
Lastly, to determine if the microstructure and ultrastructure of the Kcnq2-null is normal, 
we examined epon-embedded cross-section of femoral nerves and DRG, and longitudinal 
sections of femoral sensory axons of mutant and wild-type animals. As shown in figure 
3-10, the cross-section of both motor and sensory axons of the mutant animals showed 
normal shape and myelin sheath, while the ultra-thin sections of femoral sensory nerves 
showed that the appearance of the paranodal loops, the nodal microvilli, and the nodal 
axolemma of the Kcnq2-null sensory axons were all similar to wild-type axons (Figure 3-
11). Finally, because we had previously demonstrated that Remak fibers, but not nodes of 
Ranvier, express Kv7.5 (King et al, publication in press), we wished to determine 
whether this pattern of expression is retained in Kcnq2-mutant mice.  In both the femoral 
sensory and femoral motor branches, Remak fibers of both control and mutant mice 
showed robust Kv7.5 immunostaining. Nodes were Kv7.5-negative (Fig. 3-12), 
indicating that Kv7.3 forms homomeric channels in the Kcnq2-null axons. 
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 Because our X-gal staining appears to show that all DRG neurons express Pax3-
Cre, we confirmed that Kv7.2 expression is abolished in Kcnq2-null DRG by 
immunostaining unfixed DRG sections taken from both mutant and wild-type animals 
with the Kv7.2 antiserum (Figure 3-13). In the wild-type animals the Kv7.2 antiserum 
predominately labeled larger diameter DRG neurons (which were panNav-negative), 
while the panNav antibody primarily labeled smaller diameter neurons. In contrast, in the 
mutant animals, we did not detect Kv7.2 staining in any neuron, while the panNav 
antibody retained its wild-type staining pattern. Similar to our teased nerve results, nodes 
in the Kcnq2-null DRG lack Kv7.2 immunostaining. In addition, we had also examined 
unfixed trigeminal ganglia sections taken from the same groups of animals (Figure 3-14), 
and we detected a similar loss of Kv7.2 immunostaining in the neurons and nodes of 
mutant animals. As the trigeminal ganglion is analogues to the DRG, and also is neural 
crest-derived, this result further indicate that Kv7.2 expression was lost in all neural 
crest-derived sensory neurons. Finally, in order to demonstrate the lack of recombined 
Kcnq2 allele in non-neural crest derived-tissue, we performed PCR on DNA samples 
isolated from DRG, trigeminal, and liver of mutant animals. As shown in figure 3-1 panel 
C, while both the floxed and recombined Kcnq2 alleles were detected in the DRG and 
trigeminal ganglia, only the floxed allele was detected in the liver, indicating that the 
Kcnq2 allele was being selectively deleted in neural crest-derived tissues. 
 
Conditional Kcnq2-null mice exhibited normal motor performance 
 67 
Although our immunohistochemical assays seem to indicate normal Kcnq2 expression in 
the peripheral motor axons of our mutant animals, our X-gal staining suggest that it is 
possible for Kv7.2 expression to be altered in non-sensory tissues of our Kcnq2-null 
animals. Therefore we used the rotarod to test the motor performance of the mutant 
animals. As shown in figure 3-15, all mice tested (nine mutant and nine wild-type 
littermates) learned the test equally well, and showed similar performance improvement 
over the nine testing sessions. The average time to fall for all sessions was statistically 
equal between the mutant (162.63 ± 12.87 seconds) and wild-type (169.89 ± 6.12 
seconds) groups (P = 0.62). Therefore, the conditional deletion of Kcnq2 did not appear 
to affect the motor performance of mutant animals. 
 
Conditional Kcnq2-null mice showed increased signs of mechanical allodynia and 
thermal hyperalgesia 
A previous study on the role of M-current in behavior models of pain have reported that 
local injection of the Kv7-blocker XE991 in normal uninjured rat hindpaws did not 
produce mechanical allodynia (Linley et al., 2008). However, because XE-991 is not 
Kv7.2-specific (Wang et al., 1998, Wang et al., 2000, Schwarz et al., 2006), we examined 
our Kcnq2-null mice to see if decreased Kv7.2-expression correlates to increased 
mechanical allodynia. To do so, we measured pain withdrawal threshold using von Frey 
filaments. As shown in figures 3-16, the Kcnq2-null mice on average had a lower 
withdrawal threshold (0.65 ± 0.07g) compared to the wild-type littermates by a 
statistically significant amount (0.93 ± 0.09g; P < 0.05). 
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Dost et al. (2004) reported that intraperitoneal injection of retigabine was able to 
reduce signs of thermal hyperalgesia in rats, but another study found oral administration 
of retigabine had no effect against acute noxious thermal stimuli in rats (Blackburn-
Munro and Jensen, 2003). To address this conflict, and to investigate if lower Kv7.2 
expression can increase thermal hyperalgesia, we measured the withdrawal latency of the 
mutant and wild-type animals from noxious thermal stimuli using the Hargreaves’ test. 
As shown in figure 3-17, the Kcnq2-null mice on average exhibited shorter withdrawal 
latency (3.73±0.164 seconds) versus the wild-type littermates by a statistically significant 
amount (4.28 ± 0.158 seconds; p < 0.05). Taken together, our results suggest that loss of 
Kv7.2 expression can lead to increased mechanical allodynia and thermal hyperalgesia. 
 
Conditional Kcnq2-null mice showed increased AHP peak undershoot and 
decreased spike frequency adaptation 
In a previous study using a dominant negative mutation of Kv7.2 to suppress M currents 
in the mouse hippocampus, Peters et al. (2005) found that the mutant CA1 pyramidal 
neurons exhibited decreased spike-frequency adaptation, and these changes can be 
replicated in the control neurons by the application of XE991, demonstrating that the 
altered biophysical properties of the mutant neurons were a result of M-current 
suppression. In this study we examined the electrophysiological properties of the Kcnq2-
null DRG neurons. In addition, we utilized the M-channel blocker TEA, which at 3 mM 
should primarily affect only Kv7.2 (and Kv7.2/Kv7.3 heteromers) but no other Kv7 
subunits (Wang et al., 1998, Hadley et al., 2000, Lerche et al., 2000, Hadley et al., 2003). 
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We first dissociated and cultured twenty-five lumbar DRG neurons from each genotype 
(five wild-type and five mutant mice), then we used whole cell patch-clamp recording 
techniques to examine the passive membrane properties and firing properties of DRG 
neurons (Table 3-1). While we recorded from various neuron sizes, the average cell size 
recorded from each genotype (as estimated from membrane capacitance) was not 
statistically different between the control and Kcnq2-null groups (38.75 ± 3.3 pF versus 
45.3 ± 4.14 pF, respectively).  
To investigate the afterhyperpolarization (AHP) properties, we elicited single AP 
with brief (3-ms) depolarizing current steps, and measured both the peak undershoot 
(most negative potential during the AHP, in mV) as well as the duration (in ms) of AHPs 
from each neuron. As shown in figure 3-18, prior to TEA application the average AHP 
peak undershoot of mutant DRG neurons was 3.92% more negative than wild-type 
neurons (-85.7 ± 0.97 mV versus -82.47 ± 1.28 mV, respectively; P < 0.05), while the 
AHP duration was not statistically different between the two groups (262.9 ± 39.91 ms 
versus 205.97 ± 31.79 ms, respectively). After 3mM TEA application, both the AHP 
duration and peak magnitude of the wild-type neurons did not change by a statistically 
significant amount (221.63 ± 48.58 ms and -83.92 ± 1.21 mV, respectively). 
Furthermore, the AHP properties of the mutant neurons also were not affected by TEA 
application.  
 Next, we examined the AP firing patterns and spike-frequency adaptation by 
injecting 500-ms depolarizing current steps into DRG neurons. For each neuron, a 
threshold current (rheobase) was determined with incremental (100 pA) 500-ms current 
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steps, starting from 0.1 nA. Then we applied 500-ms depolarizing current steps to 1, 2, 
and 3 times rheobase and recorded the number of APs evoked by each current step. To 
determine the responsiveness of DRG neurons to absolute (as opposed to relative 
threshold) depolarizing stimuli, we injected a series of 500-ms incremental current steps 
(0.1-0.9 nA). As shown in figure 3-19, the Kcnq2-null neurons produced significantly 
more APs and exhibited less spike-frequency adaptation than control neurons. In 
addition, 3 mM TEA was able to significantly increase the number of APs and decrease 
spike-frequency adaptation in control neurons more than in cells from mutant mice. 
Lastly, TEA decreased the rheobase of wild-type neurons by 49% (Table 1; 0.39 ± 0.07 
nA from 0.77 ± 0.23 nA; P < 0.05), which is also statistically different than mutant 
neurons after TEA (0.88 ± 0.19 nA); on the other hand, the rheobase of the mutant was 
not affected by TEA (0.88 ± 0.19 nA from 0.81 ±0.16 nA). Therefore, the lack of Kcnq2 
expression in mutant DRG neurons was associated with increased excitability and 
decreased spike-frequency adaptation, and this hyper-excitability could be replicated in 
wild-type neurons by the application of Kv7.2-specific concentration of TEA. 
 
DISCUSSION 
Deleting Kcnq2 enabled us to investigate directly the role of Kv7.2 in sensory 
neurons. Deleting Kv7.2 had no discernible effect on the structure of myelinated axons, 
or on the motor performance of the mutant animals. There were modest effects on both 
acute thermal and mechanical nociceptive behaviors, and on the electrophysiological 
properties of sensory neurons. 
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Kv7.3 nodal expression does not depend on Kv7.2 
Our data confirm that Kv7.2 and Kv7.3 are found at nodes (Devaux et al., 2004, 
Pan et al., 2006, Schwarz et al., 2006), although we document an even greater extent of 
their colocalization. This finding suggests that Kv7.2/Kv7.3 heteromers are the main Kv7 
channels at PNS nodes. The localization of Kv7.3 at Kcnq2-null nodes demonstrates that 
nodal Kv7.3 expression does not require Kv7.2, in contrast to previous in vitro studies 
(Schwake et al., 2000, Gomez-Posada et al., 2010). Because both Kv7.2 and Kv7.3 
contain an ankyrin-G binding domain in their C-termini (Pan et al., 2006), it is reasonable 
to expect that Kv7.3 could be selectively retained at nodes and AIS. Indeed, the deletion 
of the ankyrin-G binding motif in Kv7.2 alone does not alter the AIS localization of 
Kv7.2/Kv7.3 heteromers (Rasmussen et al., 2007). In addition, the normal molecular 
components of nodes (panNav), paranodes (Caspr), and juxtaparanodes (Kv1.1), as well 
as ultrastructure of Kcnq2-null sensory myelinated axons, shows that these features do 
not depend on Kv7.2. Finally, we found that Kv7.5 expression in Remak bundles is 
maintained in Kcnq2-null nerves. While Kv7.5 and Kv7.3 can form heteromeric channels 
in vitro (Schroeder et al., 2000), we did not detect Kv7.5-immunoreactivity at Kcnq2-null 
nodes, suggesting that in our mutant animals, the nodal Kv7 channels are comprised of 
Kv7.3 homomers. 
 
Kv7.2 contributes to the regulation of neuronal excitability 
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Kv7 channels activate at subthreshold potentials and do not become inactivated, 
thereby contributing to the regulation of neuronal excitability (Brown and Passmore, 
2009). This has been documented with a variety of ways: Kv7 blockers (linopridine or 
XE991), dominant-negative Kv7.2 mutants, or decreased Kv7.2 expression have all been 
shown to increase excitability (decreased spike-frequency adaptation and/or increased 
number of action potentials) of hippocampal neurons (Aiken et al., 1995, Yue and Yaari, 
2004, Gu et al., 2005, Peters et al., 2005, Shah et al., 2008) and of somatic and visceral 
sensory neurons (Passmore et al., 2003, Rivera-Arconada and Lopez-Garcia, 2005, 
Wladyka and Kunze, 2006, Wladyka et al., 2008). Kv7 enhancer (retigabine) produces 
the opposite effects (Lerche et al., 2000, Brueggemann et al., 2007). In isolated rat 
peripheral nerves, retigabine slows axonal conduction, and these effects can be reversed 
by application of 20 µM linopridine or 10 mM TEA (Devaux et al., 2004). Schwarz et al. 
(2006) showed that XE991 both abolishes the slow accommodation to the depolarization 
and the post-depolarization undershoot of action potential at nodes, as well as increases 
repetitive firing and decreases spike-frequency adaptation in rat motor axons. Taken 
together, these results indicate that Kv7 channels regulate both neuronal and axonal 
activity. 
Our analysis of Kcnq2-null DRG neurons confirmed and extended these prior 
works. By using TEA at a Kv7.2-specific concentration (Wang et al., 1998, Hadley et al., 
2000, Lerche et al., 2000, Hadley et al., 2003), we showed that Kv7.2 contributes to the 
spike-frequency adaptation of sensory neurons. Because TEA did not further decrease 
spike-frequency adaptation in Kcnq2-null neurons, decreased Kv7.2 activity is the most 
parsimonious explanation for the increased excitability of the Kcnq2-null neurons. While 
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we did not see any decrease in the rheobase of the mutant neurons pre-TEA application, it 
is possible that Kv7.3, which is also expressed in DRG neurons (Passmore et al., 2003), is 
sufficient to maintain normal rheobase in the absence of Kv7.2.  
Classically, AHP can be subdivided into three phases: fast (1-5 ms), medium (50-
200 ms), and slow (500 ms to several seconds) AHP (Madison and Nicoll, 1984, Storm, 
1990, Gu et al., 2005). Because the slow activation speed of the M channels (tens of 
milliseconds), they do not contribute materially to the fast AHP (Brown and Passmore, 
2009), which is instead considered to be mediated by the Big Potassium (BK) family of 
potassium channels (Storm, 1990). Indeed, our Kcnq2-null neurons exhibited only 
slightly more negative fast AHP amplitude compared to control neurons, and the 
application of TEA did not produce statistically significant changes in fast AHP 
amplitudes in both mutant and control neurons. The negative TEA results indicate that 
Kv7.2 does not play an appreciable role in the fast AHP. While we cannot explain why 
the fast AHP amplitude of our Kcnq2-null neurons was actually slightly more negative 
compared to the control neurons, the fact that Kv7.2-specific concentration of TEA did 
not change the fast AHP amplitude of the control neurons suggest that this difference 
may not be due to the lack of Kv7.2 activity. 
On the other hand, the identity of the channel(s) that mediates the slow AHP is 
still uncertain (Tzingounis and Nicoll, 2008, Matthews et al., 2009), but decreases in 
Kv7.2 or Kv7.5 activity has been shown to reduce slow AHP in mouse hippocampal 
neurons (Tzingounis and Nicoll, 2008, Tzingounis et al., 2010). Our Kcnq2-null DRG 
neurons also displayed a decrease in slow AHP amplitude compared to control neurons, 
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and 3mM TEA was able to reduce the slow AHP amplitude of control neurons, while 
having no effect on mutant neurons. While a previous study have shown that 10 µM 
XE991 application in hippocampal had actually enhanced slow AHP, other experiments 
showed that muscarine, which suppresses Kv7 channels (Brown and Adams, 1980), was 
able to inhibit slow AHP (Ghamari-Langroudi and Bourque, 2004, Hu and Mooney, 
2005). Therefore, while the exact contribution of Kv7 channels to slow AHP remained 
uncertain, our results raise the possibility that Kv7.2 activity does contribute, at least in 
part, to slow AHP in DRG neurons. 
 
Increased mechanical allodynia and thermal hyperalgesia in Kcnq2-null mice 
 There results regarding the role of Kv7 channels on mechanical allodynia and 
thermal hyperalgesia are inconsistent. Retigabine increases the tail withdrawal threshold 
to noxious thermal stimuli at a dose-dependent manner (Dost et al., 2004). Because this 
effect was not reversed by the co-administration of linopridine, it may be due to non-
Kv7-specific effect of retigabine, and it also conflicts with another study using different 
methodology, in which found that retigabine did not affect the withdrawal response from 
noxious thermal stimuli (Blackburn-Munro and Jensen, 2003). Lastly, intraplantar 
injections of XE991 into the mice hindpaws did not induce thermal hyperalgesia or 
mechanical allodynia, with the caveat that the actual concentration of XE991 that reached 
the sensory axons cannot be established (Linley et al., 2008). The above studies shared 
the important limitation that the enhancers and blockers likely act on most or all Kv7 
subunits, and potentially other channels (for example GABAA (Otto et al., 2002)), and the 
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distribution of these subunits may be heterogenous. For example, we found that 
unmyelinated axons express Kv7.5 (King et al, publication in press), which could also be 
the site of these pharmacological agents.  
In our current study we sought to minimize these confounding factors by 
analyzing a type of myelinated sensory axons that lacks Kv7.2, the A-delta fibers. While 
the technical limitations of our behavior tests do not allow us to completely differentiate 
A-delta fiber mediated nociception from C-fiber mediated nociception, previous studies 
suggest that withdrawal reflex behavior from both acute noxious thermal stimuli (Price 
and Dubner, 1977, Dubner and Bennett, 1983, Yeomans and Proudfit, 1996, Hargreaves 
et al., 1998, Cuellar et al., 2010) and punctate mechanical stimuli (Dubner and Bennett, 
1983, Koltzenburg et al., 1993, Ziegler et al., 1999) are both primarily mediated by A-
delta fibers. Specifically, Yeomans and Proudfit (1996) found that radiant heating of rat 
hindpaw at a high rate of 6.5oC/sec for 6 seconds primarily evokes A-delta fiber response, 
while a low rate of 0.9oC/sec for 20 seconds primarily activates C-fibers response; 
notably, the C-fiber response at either heating rate did not begin until 5-8 seconds after 
onset of heating. Because the thermocouple of our Hargreaves apparatus had been shown 
to raise rat hindpaw temperature from 30oC to 49oC in 5 seconds (3.8oC/sec) (Dirig et al., 
1997), and because the average withdrawal latency of both mutant and control animals in 
our Hargreaves’ test were less than 5 seconds (3.7 sec and 4.3 sec, respectively), our 
results suggest that the increased thermal hyperalgesia behavior of our Kcnq2-null mutant 
animal was, at least in part, as a result of increased A-delta fiber activity. Furthermore, Ji 
et al. (2007) reported that rats treated with spinal nerve ligation displayed decreased 
mechanical threshold of A-delta fibers, but not of C-fibers, and simultaneously exhibited 
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increased mechanical allodynia (as tested with von Frey filaments), suggesting that the 
increased mechanical allodynia of our Kcnq2-null animals may also be due to increase A-
delta fiber activity. Taken together, the increased thermal hyperalgesia and mechanical 
allodynia exhibited by our Kcnq2-null mice suggest that the lack of Kv7.2 expression in 
the A-delta fibers may produce increased acute thermal and mechanical nociception. 
Because our rotarod test provided no evidence of different motor performance between 
our mutant and control animals, the increased nociceptive responses observed in the 
Kcnq2-null mice is unlikely to be a consequence of altered motor behavior. However, 
because our X-gal stainings indicate that Pax3-Cre expression may also be present in 
regions of the brain, the possibility exists that the loss of Kv7.2 expression within the 
central nervous system may also have played a role in the increased thermal hyperalgesia 
and mechanical allodynia exhibited by our Kcnq2 mutant mice.  
Taken together, our work raises the possibility that a decrease in Kv7.2 activity can 
increase sensory neuronal excitability, and lead to increased pain perception. 
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Figure 3-1 
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Figure 3-1: Targeting strategy to generate an inducible deletion allele of Kcnq2. 
Panel A shows the genomic arrangement of the first seven exons of wild type Kcnq2. The 
external probes a and b are indicated as horizontal green lines. The targeted allele 
contains two loxP sites (orange triangles facing down) before the third, and after the fifth 
exons. A cassette containing a neo gene under the herpes simplex Tk promoter (PtkNeo; 
yellow box), flanked by two FRT sites (purple triangles facing up) is inserted in a unique 
XhoI site in the intron between the fifth and the sixth exons. The targeting vector (not 
shown) is the same as the pictured targeted allele except that it includes a diphtheria toxin 
(DT) gene as a negative selection marker after the last EcoRV site. Mice carrying the 
floxed allele were obtained after the removal of the PtkNeo cassette by mating the 
targeted mice with a general FRT-deleter strain. The recombined allele lacks exons 3-5, 
is generated after Cre-mediated deletion.  
Panel B show the expected sizes of the amplified DNA with the different primer pairs.  
Panel C shows the PCR results of DNA isolated from DRG, trigeminal ganglia, and liver 
of Kcnq2-null mice and their control littermates, along with tail DNA from control and 
heterozygous floxed Kcnq2 mice (Kcnq2 fl/+). Samples were subjected to PCR with the 
indicated primers, and the reaction products were separated by gel electrophoresis. A 
~270 bp band, corresponding to the predicted size of wild-type Kcnq2 allele, was 
detected in both tail samples, as well as in all of the samples from the control littermates. 
A ~300 bp band, corresponding to the predicted size of the floxed Kcnq2 allele, was 
detected in the heterozygous tail, as well as in all of the Kcnq2-null samples. A ~380 bp 
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band, corresponding to the predicted size of the recombined Kcnq2 allele, was detected in 
both the DRG and the trigeminal ganglia of the Kcnq2-null mice, but not in their liver.  
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Figure 3-2 
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Figure 3-2: Expression of Wnt1-Cre, Pax3-Cre, and Avil-Cre.  
These are digital images of samples taken from Wnt1-Cre-positive (n=3), Pax3-Cre-
positive (n=3), Avil-Cre-positive (n=3), and their Cre-negative littermates (n=3 for each 
genotype) that also expressed the Rosa26 reporter gene. The sections were stained for 
beta-galactoside activity (X-gal was the chromogen), and photographed with a stereo 
dissecting microscope. None of the samples taken from any of the control animals 
showed any X-gal staining. In contrast, a majority of the cerebellum, regions of the 
cerebrum (including the cortex, the hippocampus, the thalamus, and the hypothalamus), 
and the dorsal part of the spinal cord (including the dorsal roots) were stained with X-gal 
in mice expressing Wnt1-Cre. These regions of the brain and spinal cord were also 
stained in mice expressing Pax3-Cre (but with more intense thalamic staining and no 
hippocampal or hypothalamic staining). Lastly, mice expressing Avil-Cre showed much 
less cerebellum labeling, with cerebrum staining primarily seen in the cortex and the 
hippocampus, as well as staining of the dorsal part of the spinal cord (including the dorsal 
roots). 
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Figure 3-3 
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Figure 3-3: All sensory neurons expressed Wnt1-Cre, Pax3-Cre, and Avil-Cre.  
These are digital images of 1 µm thick epoxy sections of DRG neurons from Wnt1-Cre-
positive (n=3), Pax3-Cre-positive (n=3), and Avil-Cre-positive (n=3) mice that also 
expressed the Rosa26 reporter gene. The DRGs had been labeled with X-gal. All of the 
Wnt1-Cre, Pax3-Cre, and Avil-Cre-positive neurons showed X-gal staining (blue). Scale 
bar: 20 µm. 
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Figure 3-4 
 
 
Figure 3-4: Selective loss of Kcnq2 from the nodes of sensory axons.  
These are digital images of unfixed teased fibers, double-labeled for Kv7.2 (red) and 
voltage-gated sodium channels (panNav; green). In the femoral sensory branch, Kv7.2 is 
found at all nodes of Ranvier (arrows) in wild-type animals, but is not detected at any 
nodes (arrowheads) in Kcnq2-null animals. In the femoral motor branch, Kv7.2 is found 
at all nodes of Ranvier (arrows) in wild-type animals, but is not detected at some nodes 
(arrowheads) in Kcnq2-null animals. Scale bar: 10 µm. 
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Figure 3-5 
 
 
 
Figure 3-5: Kv7.2 antiserum recognized Kv7.2 but not Kv7.3.  
These are images of HeLa cells transiently transfected to express human Kv7.2 or Kv7.3, 
labeled with the indicated antiserum and counterstained with DAPI. Note that the Kv7.2 
antiserum (column A) labels cells expressing Kv7.2 and not Kv7.3, and that the Kv7.3 
antiserum (column B) labels cells expressing Kv7.3 but not Kv7.2. Scale bar: 20 µm. 
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Figure 3-6 
 
 
Figure 3-6: Kv7.3 is found at all nodes in Kcnq2-null mice. 
These are digital images of unfixed mouse teased nerves, double-labeled for Kv7.3 (red) 
and panNav (green). In the femoral motor and sensory branches of both mutant and wild-
type mice, all panNav positive nodes are also Kv7.3-positive (arrows). Scale bar: 10 µm. 
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Figure 3-7 
 
 
Figure 3-7: Selective loss of Kcnq2 from the nodes of sensory axons. 
These are digital images of unfixed mouse teased nerves, double-labeled for either Kv7.2 
or Kv7.3 (red) and panNav (green). In the dorsal roots of mutant animals, Kv7.2 is not 
detected at any node (arrowheads), where Kv7.3 is found at every node (arrows). In the 
ventral roots of mutant mice, note that all nodes are Kv7.2- and Kv7.3-positive (arrows). 
Scale bar: 10 µm. 
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Figure 3-8 
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Figure 3-8: Selective loss of Kcnq2, but not Kcnq3, from the nodes of sensory axons. 
The bar graphs represent average proportion of panNav-positive nodes that are Kv7.2- 
(panel A) or Kv7.3- (panel B) positive from the indicated source (n=3 for all samples). 
Note that ~0% of nodes in the dorsal root and femoral sensory branch, and 50% in the 
femoral motor branch, were Kv7.2-positive. Error bars represent SEM; * P < 0.05; ** P 
<0.01 (two-way ANOVA).  
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Figure 3-9 
 
Figure 3-9: The molecular components of nodes, paranodes and juxtaparanodes are 
maintained in Kcnq2-null sensory axons. 
These are digital images of teased fibers from unfixed mutant sciatic nerves, double-
labeled for Kv7.2 (red) and either panNav (column A), Caspr (column B), or Kv1.1 
(column C); all green. The selected nodal (panNav), paranodal (Caspr) and 
juxtaparanodal (Kv1.1) components are the same for myelinated axons with Kv7.2-
positive (motor axons) or Kv7.2-negative (sensory axons) nodes. Scale bar: 10 µm. 
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Figure 3-10 
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Figure 3-10: Kcnq2-null sensory axons in femoral sensory branch and dorsal root 
have normal cross-sectional appearance 
These are digital images of 1 µm-thick Kcnq2-null femoral nerve and DRG cross-
sections, stained with toluidine blue. First panel of column A shows a 20x magnification 
of the femoral nerve cross-section, with the division between motor (M) and sensory (S) 
branch approximately demarcated by the red line. The 100x magnification of both 
femoral motor and sensory branches show that myelinated axons look normal. First panel 
of column B shows a 10X magnification of the DRG cross-section, with accompanied 
ventral (VR) and dorsal (DR) roots. The 100x magnification of both ventral and dorsal 
roots show that myelinated axon look normal. Scale bars at all magnification: 20 µm.   
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Figure 3-11 
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Figure 3-11: Kcnq2-null sensory axons have normal nodal and paranodal 
ultrastructure. 
These are digital images of ultra-thin sections of femoral sensory nerves from wild-type 
(panel A) and mutant (panel B) mice. The appearance of the paranodal loops (PL), the 
nodal microvilli (Mv), and the nodal axolemma (arrowheads), were all similar. Scale bar: 
500 nm. 
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Figure 3-12 
 
 
Figure 3-12: Remak fiber expression of Kv7.5 is maintained in Kcnq2 mutant mice 
These are digital images of unfixed mouse teased nerves, double-labeled for Kv7.5 (red) and 
panNav (green). In the femoral sensory and motor branches of both mutant and wild-type mice, 
all panNav-positive Remak fibers are Kv7.5-positive (chevrons), while all panNav-positive nodes 
are Kv7.5-negative (arrowheads). Scale bar: 10 µm. 
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Figure 3-13
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Figure 3-13: DRG neurons of Kcnq2-null mice do not express Kv7.2. 
These are images of unfixed sections of lumbar dorsal root ganglia (DRG), double-
labeled with a rabbit antiserum against Kv7.2 (red) and a panNav monoclonal antibody 
(green). In wild-type DRG (column A), the Kv7.2 antiserum labels large diameter 
neurons, one of which is indicated (arrow); these are relatively unlabeled by the panNav 
antibody. In contrast, in Kcnq2-null DRG (column B), the Kv7.2 antiserum does not label 
large neurons. In both wild-type and Kcnq2-null DRG, the panNav monoclonal labels 
small neurons, two of which are indicated (arrowhead). In addition, all nodes of wild-type 
neurons are double-labeled by both Kv7.2 and panNav (some enclosed within a circle), 
while none of the nodes of mutant neurons are Kv7.2-positive. Scale bar: 20 μm. 
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Figure 3-14 
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Figure 3-14: Trigeminal neurons of Kcnq2-null mice do not express Kv7.2. 
These are images of unfixed sections of trigeminal ganglia, double-labeled with rabbit 
antiserum against Kv7.2 (red) and a panNav monoclonal antibody (green). In wild-type 
trigeminal ganglia (column A), the K7.2 antiserum labeled neurons that are relatively 
unlabeled by the panNav antibody, one of which is indicated (arrow). In contrast, in 
Kcnq2-null trigeminal ganglia (column B), the Kv7.2 antiserum does not label any 
neurons. In both wild-type and Kcnq2-null trigeminal ganglia, the panNav monoclonal 
labels small neurons, two of which are indicated (arrowhead). In addition, all nodes of 
wild-type neurons are double-labeled by both Kv7.2 and panNav (some enclosed within a 
circle), while none of the nodes of mutant neurons are Kv7.2-positive. Scale bar: 20 μm. 
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Figure 3-15 
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Figure 3-15: Kcnq2-null mice exhibited similar motor performance as control mice. 
Mutant mice (n=9) and their wild-type littermates (n=9) were subjected to three 
consecutive days of testing on a rotarod (three tests per day), with motor performance 
measured by the time it took the mice to fall off the rotarod. Both the mutant and wild-
type mice displayed a similar increase in motor performance over the course of nine 
testing sessions, with no statistical difference between the two groups (panel A; repeated 
measures ANOVA). In addition, that there was no statistical difference in the overall 
average time to fall between the mutant and control animals (panel B). Error bars 
represent SEM; N.S. = no significant difference (unpaired two-sample Student’s t-test 
with equal variance). 
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Figure 3-16 
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Figure 3-16: Kcnq2-null mice displayed increased mechanical allodynia. 
Both mutant mice (n=9) and wild-type littermates (n=9) were subjected to three 
consecutive days of testing with a series of von Frey hair filaments (0.4g, 0.6g, 1.0g, 
1.4g, 2.0g; one up-and-down session per day). Mechanical allodynia determined by the 
lowest strength of hair filament capable of inducing a positive withdrawal response. The 
mutant animals showed consistently lower withdrawal threshold in each of the three 
testing days; this was significant only the first day (panel A). The overall average of all 
tests showed mutant animals have a statistically significant increase in mechanical 
allodynia (panel B). Error bars represent SEM; * P < 0.05 (unpaired two-sample 
Student’s T-test with equal variance). 
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Figure 3-17 
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Figure 3-17: Kcnq2-null mice have increased thermal hyperalgesia. 
Both mutant mice (n=9) and their wild-type littermates (n=9) were subjected to four 
consecutive days (six trials per day) of thermal hyperalgesia measured by the withdrawal 
latency after thermal stimulation (on a Hargreaves chamber). The mutant animals showed 
consistently lower withdrawal latency during each of the four testing days; this was 
significant only the first day (panel A). The overall average of all tests showed mutant 
animals have a statistically significant increase in thermal hyperalgesia (panel B). Error 
bars represent SEM; * P < 0.05 (unpaired two-sample Student’s t-test with equal 
variance). 
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Figure 3-18 
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Figure 3-18: Kcnq2-null DRG neurons have a diminished slow afterhyperpolization 
(AHP) that is not affected by 3 mM TEA. 
Panel A shows representative responses from a control DRG neuron given a brief (3 ms) 
depolarizing current step that generated a single action potential (AP), and a prolonged 
(500 ms) depolarizing current step that generated multiple APs, from which the 
magnitude of the fast and slow AHP peak undershoots, respectively, were measured.  
Panel B shows that before 3 mM TEA, the average fast AHP peak undershoot of mutant 
neurons (n=25) was slightly more negative than that of control neurons (n=25). After 
applying 3 mM TEA, the fast AHP peak undershoot of both control and Kcnq2-null 
neurons did not change by a statistically significant amount.  
Panel C shows that before 3 mM TEA, the average slow AHP peak undershoot of mutant 
neurons (n=25) was 8.8% more positive than that of control neurons (n=25) . After 
applying 3 mM TEA for 2 minutes, the slow AHP peak undershoot of control neurons 
became 11% more positive, while the slow AHP peak undershoot of Kcnq2-null neurons 
did not change by a statistically significant amount. * p<0.05; ** p<0.01 (2-way 
ANOVA). 
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Figure 3-19 
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Figure 3-19: Kcnq2-null DRG neurons have decreased spike-frequency adaption 
that is not affected by 3 mM TEA. 
Single DRG neurons were injected with 500 ms depolarizing current steps of 1x, 2x, or 
3x rheobase (A-F) into the cell from a holding level of between -50 to -60 mV before and 
after application of 3 mM TEA. Panels A-D show representative recordings of control 
(A&D) and mutant (B&E) neurons, before and after application of 3 mM TEA for 2 
minutes. Panels C and F are summary diagrams showing the number of APs in mutant 
and control neurons, before and after applying TEA, respectively (* p<0.05; two-ways 
repeated measures ANOVA). Notably, after TEA application, control DRG neurons also 
showed a decrease in spike frequency adaption, and generated statistically similar 
numbers of APs at each rheobase as compared to mutant (n.s. = no significant difference; 
two-ways repeated measures ANOVA). In contrast, TEA application did not reduce 
spike-frequency adaptation of the mutant DRG neurons. In addition, we also injected 500 
ms incremental current at set current step from 0.4nA to 3.6nA (in increments of 0.4nA) 
in order to determine the responsiveness of DRG neurons to absolute (as opposed to 
relative threshold as described above) depolarizing stimuli, and the spike frequency 
adaption was also significantly reduced in mutant DRG neurons in comparison to control 
neurons before TEA application; after TEA application the control neurons generated 
statistically similar number of APs in response to absolute stimuli as compared to mutant 
neurons. 
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Table 3-1 
 control Kcnq2-null 
Passive properties   
Cm (pF) 39 ± 3.3 45 ± 4.1 
Pre-drug firing properties   
Fast AHP peak (mV) -83 ± 1.3 -86 ± 0.97* 
AP rheobase (nA) 0.77 ± 0.23 0.81 ± 0.16 
1 times rheobase (#APs) 2.1 ± 0.38 2.9 ± 0.75 
2 times rheobase (#APs) 5.8 ± 1.3 11 ± 2.8 
3 times rheobase (#APs) 8.0 ± 1.3 17. ± 4.4* 
Absolute stimulus (#APs) 16 ± 1.6 25 ± 5.2* 
Slow AHP peak (mV) -74 ± 1.9 -68 ± 1.2** 
Post-drug firing properties   
Fast AHP peak (mV) -82 ± 0.97 -84 ± 1.21 
AP rheobase (nA) 0.39 ± 0.07 0.88 ± 0.19* 
1 times rheobase (#APs) 4.0 ± 1.1 2.5 ± 0.66 
2 times rheobase (#APs) 11 ± 2.0 9.2 ± 2.2 
3 times rheobase (#APs) 13 ± 2.2 16 ± 2.9 
Absolute stimulus (#APs) 21 ± 2.2 23 ± 3.9 
Slow AHP peak (mV) -66 ± 1.2 -67 ± 1.6 
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Table 3-1: Passive and active membrane properties of control and Kcnq2-null DRG 
neurons. 
Twenty-five DRG neurons from five animals were recorded in the control and Kcnq2-
null groups. Values are means ± SEM. Cm = membrane capacitance; AHP = 
afterhyperpolarization potential; fast AHP peak = AHP undershoot peak magnitude after 
single 3-ms stimulus; AP rheobase = either the minimum amount of current required to 
evoke a single AP, or 0.1 nA (whichever one was smallest); 1, 2, and 3 times rheobase = 
the number of APs fired by a DRG neuron during a 500-ms depolarizing current step of a 
magnitude 1, 2, or 3 times its rheobase, respectively; absolute = the maximum number of 
APs fired in response to a single 500-ms depolarizing current step of 0.1-0.9 nA 
magnitude (in 0.1-nA increments); slow AHP peak = AHP undershoot magnitude after 
500-ms stimulus at 0.4nA. Values of Cm of the control DRG neurons were compared to 
mutant neurons using unpaired 2-sample Student’s t-test with equal variance; AHP and 
AP rheobase were compared with 2-way ANOVA with Tukey test; numbers of APs were 
compared with two-way repeated measures ANOVA. * p<0.05; ** p<0.01.  
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS 
 
In this thesis I used immunohistochemical, behavioral, and electrophysiological tests to 
investigate the role of Kv7 in peripheral axons. While I was able to demonstrate the 
dichotomous expression of Kv7.2 and Kv7.5 in the myelinated and unmyelinated sensory 
axons, and also investigated the role of Kv7.2 in the regulation of myelinated axonal 
excitability, there are a number of possible future projects that should be undertaken to 
expand on the findings reported in this thesis. 
 
The generation of other Kcnq-null mice 
The Kcnq2-null mice allowed me study the specific expression and activity of Kv7.2 
subunit while avoiding the disadvantages of using Kv7 blockers. However, because we 
have shown that the expression of Pax3-Cre is not limited to peripheral sensory neurons, 
I am unable to conclude that the lack of Kv7.2 activity in the peripheral sensory neurons 
is the cause of the increased thermal hyperalgesia and mechanical allodynia exhibited by 
the Kcnq2-null mice. Therefore, if and when a sensory neuron specific Cre line becomes 
available, it should be mated with mice carrying the floxed Kcnq2 allele to generate 
sensory neuron-specific Kcnq2-null mice. Furthermore, although we had first 
hypothesized that proper Kv7.3 nodal localization depends on Kv7.2, our findings 
suggest that this is not the case. Thus we cannot exclude the possibility that Kv7.3 may at 
least be partially compensating the loss of Kv7.2 activity in our Kcnq2-null mice and 
masking the resulting behavioral and electrophysiological changes. To address this issue 
we should generate mice with double-knockout of Kcnq2 and Kcnq3, which should 
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completely lack Kv7 activity in the myelinated sensory axons, and thus completely lack 
M-current. Furthermore, having such animals will also allow us to validate my Kv7.3 
antiserum. In fact, Tzingounis and Nicoll (2008) have demonstrated that, unlike Kcnq2-
null mice, Kcnq3-null animals are viable, so it is technically feasible to create double-null 
animals by crossing our conditional Kcnq2-null mice with their Kcnq3-null mice, and this 
approach should allow us to further understand the functional role of Kv7 channels in 
peripheral myelinated axons. Finally, although Kcnq5-null animal is currently 
unavailable, the generation of such animal will provide the ultimate method of 
confirming Kv7.5 expression in the Remak fibers, and electrophysiological studies of 
such animals should confirm if Kv7.5 does contribute to the regulation of C-fiber 
activity.  
 
M-current-specific recording 
As I have discussed in the introduction, Kv7 channels mediate spike-frequency 
adaptation and regulate neuronal excitability by generating M-current. Therefore, in 
chapter 3 I used decreased spike-frequency adaptation to indirectly demonstrate the lack 
of M-current in the Kcnq2-null DRG neurons. However, in their investigation of the 
functional role of Kv7 in nodose ganglia, Wladyka and Kunze (2006) used a novel 
pharmacological approach to separate M-current from other endogenous potassium 
currents, which normally only constitutes a small component of the total outward 
potassium current (Brown and Yu, 2000). They first applied the potassium channel 
blocker 4-AP, which because it blocks M-current poorly (Robbins, 2001), results in the 
elimination of the majority of non-Kv7 potassium currents. Next they used linopirdine or 
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XE991 to isolate the M-current from other 4-AP-insenstive current. (Wladyka and 
Kunze) found that along with M-current, this method blocks two other currents: a 
transient Kv4.3-like current that is present in most neurons by P3, which they minimized 
by recording from P1 cells, and a much faster activating current, which can also be 
minimized because its block by linopirdine or XE991 is rapidly reversible (while the M-
current remain blocked throughout the course of their experiment). Thus, they were able 
to obtain total isolation of the M-current by subtracting the irreversibly blocked current 
from the total current recorded before linopirdine application. By using this method, the 
authors were able to measure M-current in both nodose ganglia and arterial baroreceptors 
(Wladyka and Kunze, 2006, Wladyka et al., 2008).  
 I believe their method should also allow us to directly measure M-current in the 
Kcnq2-null DRG neurons, and should allow us better determine if Kcnq2-null neurons 
have decreased M-current. We are currently in the process setting up collaboration with 
Dr. Diana Kunze's lab, and are shipping our Kcnq2-null mice and wild-type littermates to 
their lab. 
 
Threshold tracking 
Other than measuring spike frequency adaptation, another way to quantify axonal 
excitability is through threshold tracking, specifically by measuring the late 
subexcitability threshold. Schwarz et al. (2006) showed that, unlike superexcitability, 
which is influenced by transient sodium and fast potassium conductance, late 
subexcitability is primarily influenced by Kv7 channels. In addition, superexcitability is 
usually measured after a single conditioning stimulus, while late subexcitability is 
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measured after a conditioning train of multiple action potentials. We are currently setting 
up a collaboration with Dr. Martin Koltzenburg's lab at University College London, as he 
had used this technique before to record late subexcitability from isolated saphenous 
(femoral sensory) nerves (Achilli et al., 2009). Because we have demonstrated a complete 
loss of Kv7.2 nodal expression in the Kcnq2-null femoral sensory nerves, we expect these 
nerves to have decreased late subexcitability threshold, which if true, will help to support 
our hypothesis that the increased thermal hyperalgesia and mechanical allodynia 
exhibited by the Kcnq2-null mice is due to an increase excitability of the peripheral 
sensory axons. 
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